<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36982315</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>09</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>The Physio-Pathological Role of Group I Metabotropic Glutamate Receptors Expressed by Microglia in Health and Disease with a Focus on Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5240</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24065240</ELocationID><Abstract><AbstractText>Microglia cells are the resident immune cells of the central nervous system. They act as the first-line immune guardians of nervous tissue and central drivers of neuroinflammation. Any homeostatic alteration that can compromise neuron and tissue integrity could activate microglia. Once activated, microglia exhibit highly diverse phenotypes and functions related to either beneficial or harmful consequences. Microglia activation is associated with the release of protective or deleterious cytokines, chemokines, and growth factors that can in turn determine defensive or pathological outcomes. This scenario is complicated by the pathology-related specific phenotypes that microglia can assume, thus leading to the so-called disease-associated microglia phenotypes. Microglia express several receptors that regulate the balance between pro- and anti-inflammatory features, sometimes exerting opposite actions on microglial functions according to specific conditions. In this context, group I metabotropic glutamate receptors (mGluRs) are molecular structures that may contribute to the modulation of the reactive phenotype of microglia cells, and this is worthy of exploration. Here, we summarize the role of group I mGluRs in shaping microglia cells' phenotype in specific physio-pathological conditions, including some neurodegenerative disorders. A significant section of the review is specifically focused on amyotrophic lateral sclerosis (ALS) since it represents an entirely unexplored topic of research in the field.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Balbi</LastName><ForeName>Matilde</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacy (DIFAR), University of Genoa, Viale Cembrano 4, 16148 Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonanno</LastName><ForeName>Giambattista</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3744-5786</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy (DIFAR), University of Genoa, Viale Cembrano 4, 16148 Genova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132 Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonifacino</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3966-9874</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy (DIFAR), University of Genoa, Viale Cembrano 4, 16148 Genova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inter-University Center for the Promotion of the 3Rs Principles in Teaching &amp; Research (Centro 3R), 56122 Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milanese</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3384-0666</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy (DIFAR), University of Genoa, Viale Cembrano 4, 16148 Genova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132 Genoa, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018094">Receptors, Metabotropic Glutamate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018094" MajorTopicYN="Y">Receptors, Metabotropic Glutamate</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DAM</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">disease-associated microglia</Keyword><Keyword MajorTopicYN="N">group I metabotropic glutamate receptors</Keyword><Keyword MajorTopicYN="N">mGlu1 receptor</Keyword><Keyword MajorTopicYN="N">mGlu5 receptor</Keyword><Keyword MajorTopicYN="N">mGluR1</Keyword><Keyword MajorTopicYN="N">mGluR5</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">reactive phenotype</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>1</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36982315</ArticleId><ArticleId IdType="pmc">PMC10048889</ArticleId><ArticleId IdType="doi">10.3390/ijms24065240</ArticleId><ArticleId IdType="pii">ijms24065240</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alliot F., Godin I., Pessac B. Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Dev. Brain Res. 1999;117:145&#x2013;152. doi: 10.1016/S0165-3806(99)00113-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-3806(99)00113-3</ArticleId><ArticleId IdType="pubmed">10567732</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaie P., Patel K., Male D.K. Microglia in the human fetal spinal cord--patterns of distribution, morphology and phenotype. Dev. Brain Res. 1999;115:71&#x2013;81. doi: 10.1016/S0165-3806(99)00043-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-3806(99)00043-7</ArticleId><ArticleId IdType="pubmed">10366704</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan W.Y., Kohsaka S., Rezaie P. The origin and cell lineage of microglia: New concepts. Brain Res. Rev. 2007;53:344&#x2013;354. doi: 10.1016/j.brainresrev.2006.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresrev.2006.11.002</ArticleId><ArticleId IdType="pubmed">17188751</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz C., Gomez Perdiguero E., Chorro L., Szabo-Rogers H., Cagnard N., Kierdorf K., Prinz M., Wu B., Jacobsen S.E.W., Pollard J.W., et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science. 2012;336:86&#x2013;90. doi: 10.1126/science.1219179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1219179</ArticleId><ArticleId IdType="pubmed">22442384</ArticleId></ArticleIdList></Reference><Reference><Citation>Kierdorf K., Erny D., Goldmann T., Sander V., Schulz C., Perdiguero E.G., Wieghofer P., Heinrich A., Riemke P., H&#xf6;lscher C., et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat. Neurosci. 2013;16:273&#x2013;280. doi: 10.1038/nn.3318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3318</ArticleId><ArticleId IdType="pubmed">23334579</ArticleId></ArticleIdList></Reference><Reference><Citation>Monier A., Adle-Biassette H., Delezoide A.-L., Evrard P., Gressens P., Verney C. Entry and distribution of microglial cells in human embryonic and fetal cerebral cortex. J. Neuropathol. Exp. Neurol. 2007;66:372&#x2013;382. doi: 10.1097/nen.0b013e3180517b46.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nen.0b013e3180517b46</ArticleId><ArticleId IdType="pubmed">17483694</ArticleId></ArticleIdList></Reference><Reference><Citation>Verney C., Monier A., Fallet-Bianco C., Gressens P. Early microglial colonization of the human forebrain and possible involvement in periventricular white-matter injury of preterm infants. J. Anat. 2010;217:436&#x2013;448. doi: 10.1111/j.1469-7580.2010.01245.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-7580.2010.01245.x</ArticleId><ArticleId IdType="pmc">PMC2992419</ArticleId><ArticleId IdType="pubmed">20557401</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurz H., Christ B. Embryonic CNS macrophages and microglia do not stem from circulating, but from extravascular precursors. Glia. 1998;22:98&#x2013;102. doi: 10.1002/(SICI)1098-1136(199801)22:1&lt;98::AID-GLIA10&gt;3.0.CO;2-V.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1098-1136(199801)22:1&lt;98::AID-GLIA10&gt;3.0.CO;2-V</ArticleId><ArticleId IdType="pubmed">9436792</ArticleId></ArticleIdList></Reference><Reference><Citation>Navascu&#xe9;s J., Calvente R., Mar&#xed;n-Teva J.L., Cuadros M.A. Entry, dispersion and differentiation of microglia in the developing central nervous system. An. Acad. Bras. Cienc. 2000;72:91&#x2013;102. doi: 10.1590/S0001-37652000000100013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0001-37652000000100013</ArticleId><ArticleId IdType="pubmed">10932110</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., Mehler M.F., Conway S.J., Ng L.G., Stanley E.R., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010;330:841&#x2013;845. doi: 10.1126/science.1194637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1194637</ArticleId><ArticleId IdType="pmc">PMC3719181</ArticleId><ArticleId IdType="pubmed">20966214</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen N., Smolders S., Avila A., Notelaers K., Paesen R., Ameloot M., Br&#xf4;ne B., Legendre P., Rigo J.-M. Complex invasion pattern of the cerebral cortex bymicroglial cells during development of the mouse embryo. Glia. 2013;61:150&#x2013;163. doi: 10.1002/glia.22421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22421</ArticleId><ArticleId IdType="pubmed">23001583</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayak D., Roth T.L., McGavern D.B. Microglia development and function. Annu. Rev. Immunol. 2014;32:367&#x2013;402. doi: 10.1146/annurev-immunol-032713-120240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-032713-120240</ArticleId><ArticleId IdType="pmc">PMC5001846</ArticleId><ArticleId IdType="pubmed">24471431</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim I., Mlsna L.M., Yoon S., Le B., Yu S., Xu D., Koh S. A postnatal peak in microglial development in the mouse hippocampus is correlated with heightened sensitivity to seizure triggers. Brain Behav. 2015;5:e00403. doi: 10.1002/brb3.403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.403</ArticleId><ArticleId IdType="pmc">PMC4714636</ArticleId><ArticleId IdType="pubmed">26807334</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikodemova M., Kimyon R.S., De I., Small A.L., Collier L.S., Watters J.J. Microglial numbers attain adult levels after undergoing a rapid decrease in cell number in the third postnatal week. J. Neuroimmunol. 2015;278:280&#x2013;288. doi: 10.1016/j.jneuroim.2014.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2014.11.018</ArticleId><ArticleId IdType="pmc">PMC4297717</ArticleId><ArticleId IdType="pubmed">25468773</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyo U.B., Miner S.A., Weiner J.A., Dailey M.E. Developmental changes in microglial mobilization are independent of apoptosis in the neonatal mouse hippocampus. Brain. Behav. Immun. 2016;55:49&#x2013;59. doi: 10.1016/j.bbi.2015.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.11.009</ArticleId><ArticleId IdType="pmc">PMC4864211</ArticleId><ArticleId IdType="pubmed">26576723</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakselman S., B&#xe9;chade C., Roumier A., Bernard D., Triller A., Bessis A. Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor. J. Neurosci. 2008;28:8138&#x2013;8143. doi: 10.1523/JNEUROSCI.1006-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1006-08.2008</ArticleId><ArticleId IdType="pmc">PMC6670768</ArticleId><ArticleId IdType="pubmed">18685038</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer D.P., Lehrman E.K., Kautzman A.G., Koyama R., Mardinly A.R., Yamasaki R., Ransohoff R.M., Greenberg M.E., Barres B.A., Stevens B. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 2012;74:691&#x2013;705. doi: 10.1016/j.neuron.2012.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2012.03.026</ArticleId><ArticleId IdType="pmc">PMC3528177</ArticleId><ArticleId IdType="pubmed">22632727</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham C.L., Mart&#xed;nez-Cerde&#xf1;o V., Noctor S.C. Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J. Neurosci. 2013;33:4216&#x2013;4233. doi: 10.1523/JNEUROSCI.3441-12.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3441-12.2013</ArticleId><ArticleId IdType="pmc">PMC3711552</ArticleId><ArticleId IdType="pubmed">23467340</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkhurst C.N., Yang G., Ninan I., Savas J.N., Yates J.R., 3rd, Lafaille J.J., Hempstead B.L., Littman D.R., Gan W.-B. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell. 2013;155:1596&#x2013;1609. doi: 10.1016/j.cell.2013.11.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.11.030</ArticleId><ArticleId IdType="pmc">PMC4033691</ArticleId><ArticleId IdType="pubmed">24360280</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueno M., Fujita Y., Tanaka T., Nakamura Y., Kikuta J., Ishii M., Yamashita T. Layer V cortical neurons require microglial support for survival during postnatal development. Nat. Neurosci. 2013;16:543&#x2013;551. doi: 10.1038/nn.3358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3358</ArticleId><ArticleId IdType="pubmed">23525041</ArticleId></ArticleIdList></Reference><Reference><Citation>Pont-Lezica L., Beumer W., Colasse S., Drexhage H., Versnel M., Bessis A. Microglia shape corpus callosum axon tract fasciculation: Functional impact of prenatal inflammation. Eur. J. Neurosci. 2014;39:1551&#x2013;1557. doi: 10.1111/ejn.12508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.12508</ArticleId><ArticleId IdType="pubmed">24593277</ArticleId></ArticleIdList></Reference><Reference><Citation>Squarzoni P., Oller G., Hoeffel G., Pont-Lezica L., Rostaing P., Low D., Bessis A., Ginhoux F., Garel S. Microglia modulate wiring of the embryonic forebrain. Cell Rep. 2014;8:1271&#x2013;1279. doi: 10.1016/j.celrep.2014.07.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.07.042</ArticleId><ArticleId IdType="pubmed">25159150</ArticleId></ArticleIdList></Reference><Reference><Citation>Hattori Y. The behavior and functions of embryonic microglia. Anat. Sci. Int. 2022;97:1&#x2013;14. doi: 10.1007/s12565-021-00631-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12565-021-00631-w</ArticleId><ArticleId IdType="pmc">PMC8732885</ArticleId><ArticleId IdType="pubmed">34537900</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Barres B.A. Microglia and macrophages in brain homeostasis and disease. Nat. Rev. Immunol. 2018;18:225&#x2013;242. doi: 10.1038/nri.2017.125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2017.125</ArticleId><ArticleId IdType="pubmed">29151590</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcovitch-Natan O., Winter D.R., Giladi A., Vargas Aguilar S., Spinrad A., Sarrazin S., Ben-Yehuda H., David E., Zelada Gonz&#xe1;lez F., Perrin P., et al. Microglia development follows a stepwise program to regulate brain homeostasis. Science. 2016;353:aad8670. doi: 10.1126/science.aad8670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad8670</ArticleId><ArticleId IdType="pubmed">27338705</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo H.-J., Kwon M.-S. Aged Microglia in Neurodegenerative Diseases: Microglia Lifespan and Culture Methods. Front. Aging Neurosci. 2021;13:766267. doi: 10.3389/fnagi.2021.766267.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.766267</ArticleId><ArticleId IdType="pmc">PMC8766407</ArticleId><ArticleId IdType="pubmed">35069173</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann H., Kotter M.R., Franklin R.J.M. Debris clearance by microglia: An essential link between degeneration and regeneration. Brain. 2009;132:288&#x2013;295. doi: 10.1093/brain/awn109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awn109</ArticleId><ArticleId IdType="pmc">PMC2640215</ArticleId><ArticleId IdType="pubmed">18567623</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308:1314&#x2013;1318. doi: 10.1126/science.1110647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1110647</ArticleId><ArticleId IdType="pubmed">15831717</ArticleId></ArticleIdList></Reference><Reference><Citation>Bessis A., B&#xe9;chade C., Bernard D., Roumier A. Microglial control of neuronal death and synaptic properties. Glia. 2007;55:233&#x2013;238. doi: 10.1002/glia.20459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20459</ArticleId><ArticleId IdType="pubmed">17106878</ArticleId></ArticleIdList></Reference><Reference><Citation>Ransohoff R.M., Perry V.H. Microglial physiology: Unique stimuli, specialized responses. Annu. Rev. Immunol. 2009;27:119&#x2013;145. doi: 10.1146/annurev.immunol.021908.132528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.021908.132528</ArticleId><ArticleId IdType="pubmed">19302036</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Du X.-F., Liu C.-S., Wen Z.-L., Du J.-L. Reciprocal regulation between resting microglial dynamics and neuronal activity in vivo. Dev. Cell. 2012;23:1189&#x2013;1202. doi: 10.1016/j.devcel.2012.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2012.10.027</ArticleId><ArticleId IdType="pubmed">23201120</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyo U.B., Dailey M.E. Microglia: Key elements in neural development, plasticity, and pathology. J. Neuroimmune Pharmacol. Off. J. Soc. NeuroImmune Pharmacol. 2013;8:494&#x2013;509. doi: 10.1007/s11481-013-9434-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-013-9434-z</ArticleId><ArticleId IdType="pmc">PMC3657325</ArticleId><ArticleId IdType="pubmed">23354784</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyo U.B., Wu L.-J. Bidirectional microglia-neuron communication in the healthy brain. Neural Plast. 2013;2013:456857. doi: 10.1155/2013/456857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/456857</ArticleId><ArticleId IdType="pmc">PMC3775394</ArticleId><ArticleId IdType="pubmed">24078884</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxter P.S., Dando O., Emelianova K., He X., McKay S., Hardingham G.E., Qiu J. Microglial identity and inflammatory responses are controlled by the combined effects of neurons and astrocytes. Cell Rep. 2021;34:108882. doi: 10.1016/j.celrep.2021.108882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.108882</ArticleId><ArticleId IdType="pmc">PMC7994374</ArticleId><ArticleId IdType="pubmed">33761343</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett F.C., Bennett M.L., Yaqoob F., Mulinyawe S.B., Grant G.A., Hayden Gephart M., Plowey E.D., Barres B.A. A Combination of Ontogeny and CNS Environment Establishes Microglial Identity. Neuron. 2018;98:1170&#x2013;1183.e8. doi: 10.1016/j.neuron.2018.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.05.014</ArticleId><ArticleId IdType="pmc">PMC6023731</ArticleId><ArticleId IdType="pubmed">29861285</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmore M.R.P., Najafi A.R., Koike M.A., Dagher N.N., Spangenberg E.E., Rice R.A., Kitazawa M., Matusow B., Nguyen H., West B.L., et al. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron. 2014;82:380&#x2013;397. doi: 10.1016/j.neuron.2014.02.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.02.040</ArticleId><ArticleId IdType="pmc">PMC4161285</ArticleId><ArticleId IdType="pubmed">24742461</ArticleId></ArticleIdList></Reference><Reference><Citation>Gosselin D., Link V.M., Romanoski C.E., Fonseca G.J., Eichenfield D.Z., Spann N.J., Stender J.D., Chun H.B., Garner H., Geissmann F., et al. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell. 2014;159:1327&#x2013;1340. doi: 10.1016/j.cell.2014.11.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.11.023</ArticleId><ArticleId IdType="pmc">PMC4364385</ArticleId><ArticleId IdType="pubmed">25480297</ArticleId></ArticleIdList></Reference><Reference><Citation>Gosselin D., Skola D., Coufal N.G., Holtman I.R., Schlachetzki J.C.M., Sajti E., Jaeger B.N., O&#x2019;Connor C., Fitzpatrick C., Pasillas M.P., et al. An environment-dependent transcriptional network specifies human microglia identity. Science. 2017;356:aal3222. doi: 10.1126/science.aal3222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aal3222</ArticleId><ArticleId IdType="pmc">PMC5858585</ArticleId><ArticleId IdType="pubmed">28546318</ArticleId></ArticleIdList></Reference><Reference><Citation>F&#xfc;ger P., Hefendehl J.K., Veeraraghavalu K., Wendeln A.-C., Schlosser C., Oberm&#xfc;ller U., Wegenast-Braun B.M., Neher J.J., Martus P., Kohsaka S., et al. Microglia turnover with aging and in an Alzheimer&#x2019;s model via long-term in vivo single-cell imaging. Nat. Neurosci. 2017;20:1371&#x2013;1376. doi: 10.1038/nn.4631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4631</ArticleId><ArticleId IdType="pubmed">28846081</ArticleId></ArticleIdList></Reference><Reference><Citation>Jord&#xe3;o M.J.C., Sankowski R., Brendecke S.M., Sagar, Locatelli G., Tai Y.-H., Tay T.L., Schramm E., Armbruster S., Hagemeyer N., et al. Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation. Science. 2019;363:aat7554. doi: 10.1126/science.aat7554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aat7554</ArticleId><ArticleId IdType="pubmed">30679343</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay T.L., Mai D., Dautzenberg J., Fern&#xe1;ndez-Klett F., Lin G., Sagar, Datta M., Drougard A., Stempfl T., Ardura-Fabregat A., et al. A new fate mapping system reveals context-dependent random or clonal expansion of microglia. Nat. Neurosci. 2017;20:793&#x2013;803. doi: 10.1038/nn.4547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4547</ArticleId><ArticleId IdType="pubmed">28414331</ArticleId></ArticleIdList></Reference><Reference><Citation>Davalos D., Grutzendler J., Yang G., Kim J.V., Zuo Y., Jung S., Littman D.R., Dustin M.L., Gan W.-B. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 2005;8:752&#x2013;758. doi: 10.1038/nn1472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1472</ArticleId><ArticleId IdType="pubmed">15895084</ArticleId></ArticleIdList></Reference><Reference><Citation>Block M.L., Hong J.-S. Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism. Prog. Neurobiol. 2005;76:77&#x2013;98. doi: 10.1016/j.pneurobio.2005.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2005.06.004</ArticleId><ArticleId IdType="pubmed">16081203</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita Y., Yamashita T. Neuroprotective function of microglia in the developing brain. Neuronal Signal. 2021;5:NS20200024. doi: 10.1042/NS20200024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/NS20200024</ArticleId><ArticleId IdType="pmc">PMC7823182</ArticleId><ArticleId IdType="pubmed">33532089</ArticleId></ArticleIdList></Reference><Reference><Citation>Kettenmann H., Hanisch U.K., Noda M., Verkhratsky A. Physiology of microglia. Physiol. Rev. 2011;91:461&#x2013;553. doi: 10.1152/physrev.00011.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00011.2010</ArticleId><ArticleId IdType="pubmed">21527731</ArticleId></ArticleIdList></Reference><Reference><Citation>Pocock J.M., Kettenmann H. Neurotransmitter receptors on microglia. Trends Neurosci. 2007;30:527&#x2013;535. doi: 10.1016/j.tins.2007.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2007.07.007</ArticleId><ArticleId IdType="pubmed">17904651</ArticleId></ArticleIdList></Reference><Reference><Citation>Timmerman R., Burm S.M., Bajramovic J.J. An Overview of in vitro Methods to Study Microglia. Front. Cell. Neurosci. 2018;12:242. doi: 10.3389/fncel.2018.00242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00242</ArticleId><ArticleId IdType="pmc">PMC6087748</ArticleId><ArticleId IdType="pubmed">30127723</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch M.A. The multifaceted profile of activated microglia. Mol. Neurobiol. 2009;40:139&#x2013;156. doi: 10.1007/s12035-009-8077-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-009-8077-9</ArticleId><ArticleId IdType="pubmed">19629762</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosser C.-A., Baptista S., Arnoux I., Audinat E. Microglia in CNS development: Shaping the brain for the future. Prog. Neurobiol. 2017;149&#x2013;150:1&#x2013;20. doi: 10.1016/j.pneurobio.2017.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2017.01.002</ArticleId><ArticleId IdType="pubmed">28143732</ArticleId></ArticleIdList></Reference><Reference><Citation>Colton C.A. Heterogeneity of microglial activation in the innate immune response in the brain. J. Neuroimmune Pharmacol. Off. J. Soc. NeuroImmune Pharmacol. 2009;4:399&#x2013;418. doi: 10.1007/s11481-009-9164-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-009-9164-4</ArticleId><ArticleId IdType="pmc">PMC2773116</ArticleId><ArticleId IdType="pubmed">19655259</ArticleId></ArticleIdList></Reference><Reference><Citation>Colton C.A., Wilcock D.M. Assessing activation states in microglia. CNS Neurol. Disord. Drug Targets. 2010;9:174&#x2013;191. doi: 10.2174/187152710791012053.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152710791012053</ArticleId><ArticleId IdType="pubmed">20205642</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y., Le W. Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases. Mol. Neurobiol. 2016;53:1181&#x2013;1194. doi: 10.1007/s12035-014-9070-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-9070-5</ArticleId><ArticleId IdType="pubmed">25598354</ArticleId></ArticleIdList></Reference><Reference><Citation>Du L., Zhang Y., Chen Y., Zhu J., Yang Y., Zhang H.-L. Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target. Mol. Neurobiol. 2017;54:7567&#x2013;7584. doi: 10.1007/s12035-016-0245-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-0245-0</ArticleId><ArticleId IdType="pubmed">27830532</ArticleId></ArticleIdList></Reference><Reference><Citation>Kigerl K.A., de Rivero Vaccari J.P., Dietrich W.D., Popovich P.G., Keane R.W. Pattern recognition receptors and central nervous system repair. Exp. Neurol. 2014;258:5&#x2013;16. doi: 10.1016/j.expneurol.2014.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.01.001</ArticleId><ArticleId IdType="pmc">PMC4974939</ArticleId><ArticleId IdType="pubmed">25017883</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagasra O., Michaels F.H., Zheng Y.M., Bobroski L.E., Spitsin S.V., Fu Z.F., Tawadros R., Koprowski H. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA. 1995;92:12041&#x2013;12045. doi: 10.1073/pnas.92.26.12041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.92.26.12041</ArticleId><ArticleId IdType="pmc">PMC40292</ArticleId><ArticleId IdType="pubmed">8618840</ArticleId></ArticleIdList></Reference><Reference><Citation>Orihuela R., McPherson C.A., Harry G.J. Microglial M1/M2 polarization and metabolic states. Br. J. Pharmacol. 2016;173:649&#x2013;665. doi: 10.1111/bph.13139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13139</ArticleId><ArticleId IdType="pmc">PMC4742299</ArticleId><ArticleId IdType="pubmed">25800044</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X., Leak R.K., Shi Y., Suenaga J., Gao Y., Zheng P., Chen J. Microglial and macrophage polarization&#x2014;New prospects for brain repair. Nat. Rev. Neurol. 2015;11:56&#x2013;64. doi: 10.1038/nrneurol.2014.207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.207</ArticleId><ArticleId IdType="pmc">PMC4395497</ArticleId><ArticleId IdType="pubmed">25385337</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolicelli R.C., Sierra A., Stevens B., Tremblay M.-E., Aguzzi A., Ajami B., Amit I., Audinat E., Bechmann I., Bennett M., et al. Microglia states and nomenclature: A field at its crossroads. Neuron. 2022;110:3458&#x2013;3483. doi: 10.1016/j.neuron.2022.10.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.020</ArticleId><ArticleId IdType="pmc">PMC9999291</ArticleId><ArticleId IdType="pubmed">36327895</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo S., Wang H., Yin Y. Microglia Polarization From M1 to M2 in Neurodegenerative Diseases. Front. Aging Neurosci. 2022;14:815347. doi: 10.3389/fnagi.2022.815347.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.815347</ArticleId><ArticleId IdType="pmc">PMC8888930</ArticleId><ArticleId IdType="pubmed">35250543</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellano B., Bosch-Queralt M., Almolda B., Villacampa N., Gonz&#xe1;lez B. Purine Signaling and Microglial Wrapping. Adv. Exp. Med. Biol. 2016;949:147&#x2013;165. doi: 10.1007/978-3-319-40764-7_7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-40764-7_7</ArticleId><ArticleId IdType="pubmed">27714688</ArticleId></ArticleIdList></Reference><Reference><Citation>Calovi S., Mut-Arbona P., Sperl&#xe1;gh B. Microglia and the Purinergic Signaling System. Neuroscience. 2019;405:137&#x2013;147. doi: 10.1016/j.neuroscience.2018.12.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2018.12.021</ArticleId><ArticleId IdType="pubmed">30582977</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco R., Lillo A., Rivas-Santisteban R., Reyes-Resina I., Navarro G. Microglial Adenosine Receptors: From Preconditioning to Modulating the M1/M2 Balance in Activated Cells. Cells. 2021;10:1124. doi: 10.3390/cells10051124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10051124</ArticleId><ArticleId IdType="pmc">PMC8148598</ArticleId><ArticleId IdType="pubmed">34066933</ArticleId></ArticleIdList></Reference><Reference><Citation>Krabbe G., Matyash V., Pannasch U., Mamer L., Boddeke H.W.G.M., Kettenmann H. Activation of serotonin receptors promotes microglial injury-induced motility but attenuates phagocytic activity. Brain. Behav. Immun. 2012;26:419&#x2013;428. doi: 10.1016/j.bbi.2011.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2011.12.002</ArticleId><ArticleId IdType="pubmed">22198120</ArticleId></ArticleIdList></Reference><Reference><Citation>Iida T., Yanai K., Yoshikawa T. Histamine and Microglia. Curr. Top. Behav. Neurosci. 2022;59:241&#x2013;259. doi: 10.1007/7854_2022_322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/7854_2022_322</ArticleId><ArticleId IdType="pubmed">35538301</ArticleId></ArticleIdList></Reference><Reference><Citation>Volont&#xe9; C., Apolloni S., Parisi C., Amadio S. Purinergic contribution to amyotrophic lateral sclerosis. Neuropharmacology. 2016;104:180&#x2013;193. doi: 10.1016/j.neuropharm.2015.10.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2015.10.026</ArticleId><ArticleId IdType="pubmed">26514402</ArticleId></ArticleIdList></Reference><Reference><Citation>Woods L.T., Ajit D., Camden J.M., Erb L., Weisman G.A. Purinergic receptors as potential therapeutic targets in Alzheimer&#x2019;s disease. Neuropharmacology. 2016;104:169&#x2013;179. doi: 10.1016/j.neuropharm.2015.10.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2015.10.031</ArticleId><ArticleId IdType="pmc">PMC4848184</ArticleId><ArticleId IdType="pubmed">26519903</ArticleId></ArticleIdList></Reference><Reference><Citation>El Oussini H., Bayer H., Scekic-Zahirovic J., Vercruysse P., Sinniger J., Dirrig-Grosch S., Dieterl&#xe9; S., Echaniz-Laguna A., Larmet Y., M&#xfc;ller K., et al. Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis. Acta Neuropathol. 2016;131:465&#x2013;480. doi: 10.1007/s00401-016-1534-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1534-4</ArticleId><ArticleId IdType="pubmed">26744351</ArticleId></ArticleIdList></Reference><Reference><Citation>Barata-Antunes S., Crist&#xf3;v&#xe3;o A.C., Pires J., Rocha S.M., Bernardino L. Dual role of histamine on microglia-induced neurodegeneration. Biochim. Biophys. Acta Mol. Basis Dis. 2017;1863:764&#x2013;769. doi: 10.1016/j.bbadis.2016.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2016.12.016</ArticleId><ArticleId IdType="pubmed">28057587</ArticleId></ArticleIdList></Reference><Reference><Citation>Mecha M., Carrillo-Salinas F.J., Feli&#xfa; A., Mestre L., Guaza C. Microglia activation states and cannabinoid system: Therapeutic implications. Pharmacol. Ther. 2016;166:40&#x2013;55. doi: 10.1016/j.pharmthera.2016.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2016.06.011</ArticleId><ArticleId IdType="pubmed">27373505</ArticleId></ArticleIdList></Reference><Reference><Citation>Komorowska-M&#xfc;ller J.A., Schm&#xf6;le A.-C. CB2 Receptor in Microglia: The Guardian of Self-Control. Int. J. Mol. Sci. 2020;22:19. doi: 10.3390/ijms22010019.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22010019</ArticleId><ArticleId IdType="pmc">PMC7792761</ArticleId><ArticleId IdType="pubmed">33375006</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffy S.S., Hayes J.P., Fiore N.T., Moalem-Taylor G. The cannabinoid system and microglia in health and disease. Neuropharmacology. 2021;190:108555. doi: 10.1016/j.neuropharm.2021.108555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2021.108555</ArticleId><ArticleId IdType="pubmed">33845074</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Leak R.K., Hu X. Neurotransmitter receptors on microglia. Stroke Vasc. Neurol. 2016;1:52&#x2013;58. doi: 10.1136/svn-2016-000012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/svn-2016-000012</ArticleId><ArticleId IdType="pmc">PMC5435193</ArticleId><ArticleId IdType="pubmed">28959464</ArticleId></ArticleIdList></Reference><Reference><Citation>Volont&#xe9; C., Amadio S., Fabbrizio P., Apolloni S. Functional microglia neurotransmitters in amyotrophic lateral sclerosis. Semin. Cell Dev. Biol. 2019;94:121&#x2013;128. doi: 10.1016/j.semcdb.2019.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.04.014</ArticleId><ArticleId IdType="pubmed">31009755</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Wang D., Zhang B., Zhu J., Zhou Z., Cui L. Regulation of microglia by glutamate and its signal pathway in neurodegenerative diseases. Drug Discov. Today. 2020;25:1074&#x2013;1085. doi: 10.1016/j.drudis.2020.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2020.04.001</ArticleId><ArticleId IdType="pubmed">32320851</ArticleId></ArticleIdList></Reference><Reference><Citation>Dingledine R., Borges K., Bowie D., Traynelis S.F. The glutamate receptor ion channels. Pharmacol. Rev. 1999;51:7&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">10049997</ArticleId></ArticleIdList></Reference><Reference><Citation>Willard S.S., Koochekpour S. Glutamate, Glutamate Receptors, and Downstream Signaling Pathways. Int. J. Biol. Sci. 2013;9:948. doi: 10.7150/ijbs.6426.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.6426</ArticleId><ArticleId IdType="pmc">PMC3805900</ArticleId><ArticleId IdType="pubmed">24155668</ArticleId></ArticleIdList></Reference><Reference><Citation>Bragina L., Bonifacino T., Bassi S., Milanese M., Bonanno G., Conti F. Differential expression of metabotropic glutamate and GABA receptors at neocortical glutamatergic and GABAergic axon terminals. Front. Cell. Neurosci. 2015;9:345. doi: 10.3389/fncel.2015.00345.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00345</ArticleId><ArticleId IdType="pmc">PMC4559644</ArticleId><ArticleId IdType="pubmed">26388733</ArticleId></ArticleIdList></Reference><Reference><Citation>Giribaldi F., Milanese M., Bonifacino T., Anna Rossi P.I., Di Prisco S., Pittaluga A., Tacchetti C., Puliti A., Usai C., Bonanno G. Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis. Neuropharmacology. 2013;66:253&#x2013;263. doi: 10.1016/j.neuropharm.2012.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2012.05.018</ArticleId><ArticleId IdType="pubmed">22634363</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacino T., Rebosio C., Provenzano F., Torazza C., Balbi M., Milanese M., Raiteri L., Usai C., Fedele E., Bonanno G. Enhanced function and overexpression of metabotropic glutamate receptors 1 and 5 in the spinal Cord of the SOD1G93A mouse model of amyotrophic lateral sclerosis during disease progression. Int. J. Mol. Sci. 2019;20:4552. doi: 10.3390/ijms20184552.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20184552</ArticleId><ArticleId IdType="pmc">PMC6774337</ArticleId><ArticleId IdType="pubmed">31540330</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivero G., Vergassola M., Cisani F., Roggeri A., Pittaluga A. Presynaptic Release-regulating Metabotropic Glutamate Receptors: An Update. Curr. Neuropharmacol. 2020;18:655&#x2013;672. doi: 10.2174/1570159X17666191127112339.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X17666191127112339</ArticleId><ArticleId IdType="pmc">PMC7457419</ArticleId><ArticleId IdType="pubmed">31775600</ArticleId></ArticleIdList></Reference><Reference><Citation>Conn P.J., Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 1997;37:205&#x2013;237. doi: 10.1146/annurev.pharmtox.37.1.205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.pharmtox.37.1.205</ArticleId><ArticleId IdType="pubmed">9131252</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Antoni S., Berretta A., Bonaccorso C.M., Bruno V., Aronica E., Nicoletti F., Catania M.V. Metabotropic glutamate receptors in glial cells. Neurochem. Res. 2008;33:2436&#x2013;2443. doi: 10.1007/s11064-008-9694-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-008-9694-9</ArticleId><ArticleId IdType="pubmed">18438710</ArticleId></ArticleIdList></Reference><Reference><Citation>Spampinato S.F., Copani A., Nicoletti F., Sortino M.A., Caraci F. Metabotropic Glutamate Receptors in Glial Cells: A New Potential Target for Neuroprotection? Front. Mol. Neurosci. 2018;11:414. doi: 10.3389/fnmol.2018.00414.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00414</ArticleId><ArticleId IdType="pmc">PMC6243036</ArticleId><ArticleId IdType="pubmed">30483053</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaindl A.M., Degos V., Peineau S., Gouadon E., Chhor V., Loron G., Le Charpentier T., Josserand J., Ali C., Vivien D., et al. Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain. Ann. Neurol. 2012;72:536&#x2013;549. doi: 10.1002/ana.23626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23626</ArticleId><ArticleId IdType="pubmed">23109148</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghunatha P., Vosoughi A., Kauppinen T.M., Jackson M.F. Microglial NMDA receptors drive pro-inflammatory responses via PARP-1/TRMP2 signaling. Glia. 2020;68:1421&#x2013;1434. doi: 10.1002/glia.23790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23790</ArticleId><ArticleId IdType="pubmed">32036619</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Xie W., Le W., Beers D.R., He Y., Henkel J.S., Simpson E.P., Yen A.A., Xiao Q., Appel S.H. Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism. J. Neuropathol. Exp. Neurol. 2004;63:964&#x2013;977. doi: 10.1093/jnen/63.9.964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/63.9.964</ArticleId><ArticleId IdType="pubmed">15453095</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceprian M., Fulton D. Glial Cell AMPA Receptors in Nervous System Health, Injury and Disease. Int. J. Mol. Sci. 2019;20:2450. doi: 10.3390/ijms20102450.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20102450</ArticleId><ArticleId IdType="pmc">PMC6566241</ArticleId><ArticleId IdType="pubmed">31108947</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X.-M., Zhu J. Kainic Acid-induced neurotoxicity: Targeting glial responses and glia-derived cytokines. Curr. Neuropharmacol. 2011;9:388&#x2013;398. doi: 10.2174/157015911795596540.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/157015911795596540</ArticleId><ArticleId IdType="pmc">PMC3131729</ArticleId><ArticleId IdType="pubmed">22131947</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazio F., Ulivieri M., Volpi C., Gargaro M., Fallarino F. Targeting metabotropic glutamate receptors for the treatment of neuroinflammation. Curr. Opin. Pharmacol. 2018;38:16&#x2013;23. doi: 10.1016/j.coph.2018.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2018.01.010</ArticleId><ArticleId IdType="pubmed">29471184</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrnes K.R., Loane D.J., Faden A.I. Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders. Neurother. J. Am. Soc. Exp. Neurother. 2009;6:94&#x2013;107. doi: 10.1016/j.nurt.2008.10.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nurt.2008.10.038</ArticleId><ArticleId IdType="pmc">PMC2634659</ArticleId><ArticleId IdType="pubmed">19110202</ArticleId></ArticleIdList></Reference><Reference><Citation>Conn P.J. Physiological roles and therapeutic potential of metabotropic glutamate receptors. Ann. N. Y. Acad. Sci. 2003;1003:12&#x2013;21. doi: 10.1196/annals.1300.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1300.002</ArticleId><ArticleId IdType="pubmed">14684432</ArticleId></ArticleIdList></Reference><Reference><Citation>Battaglia G., Bruno V. Metabotropic glutamate receptor involvement in the pathophysiology of amyotrophic lateral sclerosis: New potential drug targets for therapeutic applications. Curr. Opin. Pharmacol. 2018;38:65&#x2013;71. doi: 10.1016/j.coph.2018.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2018.02.007</ArticleId><ArticleId IdType="pubmed">29529498</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicoletti F., Bockaert J., Collingridge G.L., Conn P.J., Ferraguti F., Schoepp D.D., Wroblewski J.T., Pin J.P. Metabotropic glutamate receptors: From the workbench to the bedside. Neuropharmacology. 2011;60:1017&#x2013;1041. doi: 10.1016/j.neuropharm.2010.10.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2010.10.022</ArticleId><ArticleId IdType="pmc">PMC3787883</ArticleId><ArticleId IdType="pubmed">21036182</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry-Kravis E.M., Lindemann L., J&#xf8;nch A.E., Apostol G., Bear M.F., Carpenter R.L., Crawley J.N., Curie A., Des Portes V., Hossain F., et al. Drug development for neurodevelopmental disorders: Lessons learned from fragile X syndrome. Nat. Rev. Drug Discov. 2018;17:280&#x2013;299. doi: 10.1038/nrd.2017.221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd.2017.221</ArticleId><ArticleId IdType="pmc">PMC6904225</ArticleId><ArticleId IdType="pubmed">29217836</ArticleId></ArticleIdList></Reference><Reference><Citation>Su L.-D., Wang N., Han J., Shen Y. Group 1 Metabotropic Glutamate Receptors in Neurological and Psychiatric Diseases: Mechanisms and Prospective. Neurosci. Rev. J. Bringing Neurobiol. Neurol. Psychiatry. 2022;28:453&#x2013;468. doi: 10.1177/10738584211021018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10738584211021018</ArticleId><ArticleId IdType="pmc">PMC9449437</ArticleId><ArticleId IdType="pubmed">34088252</ArticleId></ArticleIdList></Reference><Reference><Citation>Biber K., Laurie D.J., Berthele A., Sommer B., T&#xf6;lle T.R., Gebicke-H&#xe4;rter P.J., Van Calker D., Boddeke H.W.G.M. Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia. J. Neurochem. 1999;72:1671&#x2013;1680. doi: 10.1046/j.1471-4159.1999.721671.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1999.721671.x</ArticleId><ArticleId IdType="pubmed">10098876</ArticleId></ArticleIdList></Reference><Reference><Citation>Loane D.J., Stoica B.A., Pajoohesh-Ganji A., Byrnes K.R., Faden A.I. Activation of metabotropic glutamate receptor 5 modulates microglial reactivity and neurotoxicity by inhibiting NADPH oxidase. J. Biol. Chem. 2009;284:15629&#x2013;15639. doi: 10.1074/jbc.M806139200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M806139200</ArticleId><ArticleId IdType="pmc">PMC2708859</ArticleId><ArticleId IdType="pubmed">19364772</ArticleId></ArticleIdList></Reference><Reference><Citation>Mudo G., Trovato-Salinaro A., Caniglia G., Cheng Q., Condorelli D.F. Cellular localization of mGluR3 and mGluR5 mRNAs in normal and injured rat brain. Brain Res. 2007;1149:1&#x2013;13. doi: 10.1016/j.brainres.2007.02.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2007.02.041</ArticleId><ArticleId IdType="pubmed">17428452</ArticleId></ArticleIdList></Reference><Reference><Citation>Drouin-Ouellet J., Brownell A.-L.L., Saint-Pierre M., Fasano C., Emond V., Trudeau L.-E.E., L&#xe9;vesque D., Cicchetti F. Neuroinflammation is associated with changes in glial mGluR5 expression and the development of neonatal excitotoxic lesions. Glia. 2011;59:188&#x2013;199. doi: 10.1002/glia.21086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.21086</ArticleId><ArticleId IdType="pmc">PMC3983848</ArticleId><ArticleId IdType="pubmed">21125661</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittemore E.R., Korotzer A.R., Etebari A., Cotman C.W. Carbachol increases intracellular free calcium in cultured rat microglia. Brain Res. 1993;621:59&#x2013;64. doi: 10.1016/0006-8993(93)90297-Z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(93)90297-Z</ArticleId><ArticleId IdType="pubmed">8106116</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim F., Wang C.C., Gereau R.W. 4th Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice. J. Neurosci. 2001;21:3771&#x2013;3779. doi: 10.1523/JNEUROSCI.21-11-03771.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-11-03771.2001</ArticleId><ArticleId IdType="pmc">PMC6762705</ArticleId><ArticleId IdType="pubmed">11356865</ArticleId></ArticleIdList></Reference><Reference><Citation>Eder C. Ion channels in microglia (brain macrophages) Am. J. Physiol. 1998;275:C327&#x2013;C342. doi: 10.1152/ajpcell.1998.275.2.C327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.1998.275.2.C327</ArticleId><ArticleId IdType="pubmed">9688586</ArticleId></ArticleIdList></Reference><Reference><Citation>Warwick H.K., Nahorski S.R., Challiss R.A.J. Group I metabotropic glutamate receptors, mGlu1a and mGlu5a, couple to cyclic AMP response element binding protein (CREB) through a common Ca2+- and protein kinase C-dependent pathway. J. Neurochem. 2005;93:232&#x2013;245. doi: 10.1111/j.1471-4159.2005.03012.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2005.03012.x</ArticleId><ArticleId IdType="pubmed">15773922</ArticleId></ArticleIdList></Reference><Reference><Citation>Farso M.C., O&#x2019;Shea R.D., Beart P.M. Evidence group I mGluR drugs modulate the activation profile of lipopolysaccharide-exposed microglia in culture. Neurochem. Res. 2009;34:1721&#x2013;1728. doi: 10.1007/s11064-009-9999-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-009-9999-3</ArticleId><ArticleId IdType="pubmed">19479374</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrnes K.R., Stoica B., Loane D.J., Riccio A., Davis M.I., Faden A.I. Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity. Glia. 2009;57:550&#x2013;560. doi: 10.1002/glia.20783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20783</ArticleId><ArticleId IdType="pmc">PMC2644739</ArticleId><ArticleId IdType="pubmed">18816644</ArticleId></ArticleIdList></Reference><Reference><Citation>Loane D.J., Stoica B.A., Byrnes K.R., Jeong W., Faden A.I. Activation of mGluR5 and inhibition of NADPH oxidase improves functional recovery after traumatic brain injury. J. Neurotrauma. 2013;30:403&#x2013;412. doi: 10.1089/neu.2012.2589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2012.2589</ArticleId><ArticleId IdType="pmc">PMC3589874</ArticleId><ArticleId IdType="pubmed">23199080</ArticleId></ArticleIdList></Reference><Reference><Citation>Lull M.E., Block M.L. Microglial activation and chronic neurodegeneration. Neurother. J. Am. Soc. Exp. Neurother. 2010;7:354&#x2013;365. doi: 10.1016/j.nurt.2010.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nurt.2010.05.014</ArticleId><ArticleId IdType="pmc">PMC2951017</ArticleId><ArticleId IdType="pubmed">20880500</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye X., Yu L., Zuo D., Zhang L., Zu J., Hu J., Tang J., Bao L., Cui C., Zhang R., et al. Activated mGluR5 protects BV2 cells against OGD/R induced cytotoxicity by modulating BDNF-TrkB pathway. Neurosci. Lett. 2017;654:70&#x2013;79. doi: 10.1016/j.neulet.2017.06.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.029</ArticleId><ArticleId IdType="pubmed">28642149</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhat S.A., Henry R.J., Blanchard A.C., Stoica B.A., Loane D.J., Faden A.I. Enhanced Akt/GSK-3&#x3b2;/CREB signaling mediates the anti-inflammatory actions of mGluR5 positive allosteric modulators in microglia and following traumatic brain injury in male mice. J. Neurochem. 2021;156:225&#x2013;248. doi: 10.1111/jnc.14954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14954</ArticleId><ArticleId IdType="pmc">PMC7386074</ArticleId><ArticleId IdType="pubmed">31926033</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermans E., Challiss R.A. Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: Prototypic family C G-protein-coupled receptors. Biochem. J. 2001;359:465&#x2013;484. doi: 10.1042/bj3590465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj3590465</ArticleId><ArticleId IdType="pmc">PMC1222168</ArticleId><ArticleId IdType="pubmed">11672421</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco R., Ciruela F., Casad&#xf3; V., Mallol J., Gallart T., Lluis C., Franco R. Group I metabotropic glutamate receptors mediate a dual role of glutamate in T cell activation. J. Biol. Chem. 2004;279:33352&#x2013;33358. doi: 10.1074/jbc.M401761200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M401761200</ArticleId><ArticleId IdType="pubmed">15184389</ArticleId></ArticleIdList></Reference><Reference><Citation>Geurts J.J.G., Wolswijk G., B&#xf6; L., van der Valk P., Polman C.H., Troost D., Aronica E. Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis. Brain. 2003;126:1755&#x2013;1766. doi: 10.1093/brain/awg179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awg179</ArticleId><ArticleId IdType="pubmed">12805104</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrnes K.R., Loane D.J., Stoica B.A., Zhang J., Faden A.I. Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury. J. Neuroinflamm. 2012;9:43. doi: 10.1186/1742-2094-9-43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-9-43</ArticleId><ArticleId IdType="pmc">PMC3308916</ArticleId><ArticleId IdType="pubmed">22373400</ArticleId></ArticleIdList></Reference><Reference><Citation>Piers T.M., Heales S.J., Pocock J.M. Positive allosteric modulation of metabotropic glutamate receptor 5 down-regulates fibrinogen-activated microglia providing neuronal protection. Neurosci. Lett. 2011;505:140&#x2013;145. doi: 10.1016/j.neulet.2011.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2011.10.007</ArticleId><ArticleId IdType="pubmed">22015768</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue F., Stoica B.A., Hanscom M., Kabadi S.V., Faden A.I. Positive allosteric modulators (PAMs) of metabotropic glutamate receptor 5 (mGluR5) attenuate microglial activation. CNS Neurol. Disord. Drug Targets. 2014;13:558&#x2013;566. doi: 10.2174/18715273113126660199.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/18715273113126660199</ArticleId><ArticleId IdType="pubmed">24168364</ArticleId></ArticleIdList></Reference><Reference><Citation>Loane D.J., Stoica B.A., Tchantchou F., Kumar A., Barrett J.P., Akintola T., Xue F., Conn P.J., Faden A.I. Novel mGluR5 positive allosteric modulator improves functional recovery, attenuates neurodegeneration, and alters microglial polarization after experimental traumatic brain injury. Neurother. J. Am. Soc. Exp. Neurother. 2014;11:857&#x2013;869. doi: 10.1007/s13311-014-0298-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-014-0298-6</ArticleId><ArticleId IdType="pmc">PMC4391388</ArticleId><ArticleId IdType="pubmed">25096154</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanak T.J., Libbey J.E., Doty D.J., Sim J.T., DePaula-Silva A.B., Fujinami R.S. Positive modulation of mGluR5 attenuates seizures and reduces TNF-&#x3b1;(+) macrophages and microglia in the brain in a murine model of virus-induced temporal lobe epilepsy. Exp. Neurol. 2019;311:194&#x2013;204. doi: 10.1016/j.expneurol.2018.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2018.10.006</ArticleId><ArticleId IdType="pmc">PMC6263825</ArticleId><ArticleId IdType="pubmed">30316834</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho T.G., Alves-Silva J., de Souza J.M., Real A.L.C.V., Doria J.G., Vieira E.L.M., Gomes G.F., de Oliveira A.C., Miranda A.S., Ribeiro F.M. Metabotropic glutamate receptor 5 ablation accelerates age-related neurodegeneration and neuroinflammation. Neurochem. Int. 2019;126:218&#x2013;228. doi: 10.1016/j.neuint.2019.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2019.03.020</ArticleId><ArticleId IdType="pubmed">30930274</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.-N., Fan J.-K., Gu L., Yang H.-M., Zhan S.-Q., Zhang H. Metabotropic glutamate receptor 5 inhibits &#x3b1;-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson&#x2019;s disease. J. Neuroinflamm. 2021;18:23. doi: 10.1186/s12974-021-02079-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02079-1</ArticleId><ArticleId IdType="pmc">PMC7814625</ArticleId><ArticleId IdType="pubmed">33461598</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh S.J., Ahn H., Jung K.-H., Han S.J., Nam K.R., Kang K.J., Park J.-A., Lee K.C., Lee Y.J., Choi J.Y. Evaluation of the Neuroprotective Effect of Microglial Depletion by CSF-1R Inhibition in a Parkinson&#x2019;s Animal Model. Mol. Imaging Biol. 2020;22:1031&#x2013;1042. doi: 10.1007/s11307-020-01485-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11307-020-01485-w</ArticleId><ArticleId IdType="pubmed">32086763</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Zhou R., Yan H., Yin H., Wu X., Tan Y., Li L. Metabotropic glutamate receptor 5 modulates calcium oscillation and innate immune response induced by lipopolysaccharide in microglial cell. Neuroscience. 2014;281:24&#x2013;34. doi: 10.1016/j.neuroscience.2014.09.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2014.09.034</ArticleId><ArticleId IdType="pubmed">25250840</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger J.V., Dumont A.O., Focant M.C., Vergouts M., Sternotte A., Calas A.-G.G., Goursaud S., Hermans E. Opposite regulation of metabotropic glutamate receptor 3 and metabotropic glutamate receptor 5 by inflammatory stimuli in cultured microglia and astrocytes. Neuroscience. 2012;205:29&#x2013;38. doi: 10.1016/j.neuroscience.2011.12.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2011.12.044</ArticleId><ArticleId IdType="pubmed">22245498</ArticleId></ArticleIdList></Reference><Reference><Citation>Lizarraga-Valderrama L.R., Sheridan G.K. Extracellular vesicles and intercellular communication in the central nervous system. FEBS Lett. 2021;595:1391&#x2013;1410. doi: 10.1002/1873-3468.14074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.14074</ArticleId><ArticleId IdType="pubmed">33728650</ArticleId></ArticleIdList></Reference><Reference><Citation>Pistono C., Bister N., Stanov&#xe1; I., Malm T. Glia-Derived Extracellular Vesicles: Role in Central Nervous System Communication in Health and Disease. Front. Cell Dev. Biol. 2020;8:623771. doi: 10.3389/fcell.2020.623771.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.623771</ArticleId><ArticleId IdType="pmc">PMC7868382</ArticleId><ArticleId IdType="pubmed">33569385</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolicelli R.C., Bergamini G., Rajendran L. Cell-to-cell Communication by Extracellular Vesicles: Focus on Microglia. Neuroscience. 2019;405:148&#x2013;157. doi: 10.1016/j.neuroscience.2018.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2018.04.003</ArticleId><ArticleId IdType="pubmed">29660443</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceccarelli L., Giacomelli C., Marchetti L., Martini C. Microglia extracellular vesicles: Focus on molecular composition and biological function. Biochem. Soc. Trans. 2021;49:1779&#x2013;1790. doi: 10.1042/BST20210202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20210202</ArticleId><ArticleId IdType="pubmed">34415305</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo F., Bastoni M., Nigro A., Podini P., Finardi A., Casella G., Ramesh M., Farina C., Verderio C., Furlan R. Cytokines Stimulate the Release of Microvesicles from Myeloid Cells Independently from the P2X7 Receptor/Acid Sphingomyelinase Pathway. Front. Immunol. 2018;9:204. doi: 10.3389/fimmu.2018.00204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00204</ArticleId><ArticleId IdType="pmc">PMC5808348</ArticleId><ArticleId IdType="pubmed">29467770</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;a-Altamira L.E., Polazzi E., Giuliani P., Beraudi A., Massenzio F., Mengoni I., Poli A., Zuccarini M., Ciccarelli R., Di Iorio P., et al. Release of soluble and vesicular purine nucleoside phosphorylase from rat astrocytes and microglia induced by pro-inflammatory stimulation with extracellular ATP via P2X(7) receptors. Neurochem. Int. 2018;115:37&#x2013;49. doi: 10.1016/j.neuint.2017.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2017.10.010</ArticleId><ArticleId IdType="pubmed">29061383</ArticleId></ArticleIdList></Reference><Reference><Citation>Glebov K., L&#xf6;chner M., Jabs R., Lau T., Merkel O., Schloss P., Steinh&#xe4;user C., Walter J. Serotonin stimulates secretion of exosomes from microglia cells. Glia. 2015;63:626&#x2013;634. doi: 10.1002/glia.22772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22772</ArticleId><ArticleId IdType="pubmed">25451814</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianco F., Pravettoni E., Colombo A., Schenk U., M&#xf6;ller T., Matteoli M., Verderio C. Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia. J. Immunol. 2005;174:7268&#x2013;7277. doi: 10.4049/jimmunol.174.11.7268.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.174.11.7268</ArticleId><ArticleId IdType="pubmed">15905573</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang L., Wu Y., Fang C., Qu P., Gao Z. NDRG2 promoted secreted miR-375 in microvesicles shed from M1 microglia, which induced neuron damage. Biochem. Biophys. Res. Commun. 2016;469:392&#x2013;398. doi: 10.1016/j.bbrc.2015.11.098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2015.11.098</ArticleId><ArticleId IdType="pubmed">26631961</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman L.G.J., Zou J., Crews F.T. Microglial-derived miRNA let-7 and HMGB1 contribute to ethanol-induced neurotoxicity via TLR7. J. Neuroinflamm. 2017;14:22. doi: 10.1186/s12974-017-0799-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-017-0799-4</ArticleId><ArticleId IdType="pmc">PMC5264311</ArticleId><ArticleId IdType="pubmed">28118842</ArticleId></ArticleIdList></Reference><Reference><Citation>Turola E., Furlan R., Bianco F., Matteoli M., Verderio C. Microglial microvesicle secretion and intercellular signaling. Front. Physiol. 2012;3:149. doi: 10.3389/fphys.2012.00149.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2012.00149</ArticleId><ArticleId IdType="pmc">PMC3357554</ArticleId><ArticleId IdType="pubmed">22661954</ArticleId></ArticleIdList></Reference><Reference><Citation>Prada I., Furlan R., Matteoli M., Verderio C. Classical and unconventional pathways of vesicular release in microglia. Glia. 2013;61:1003&#x2013;1017. doi: 10.1002/glia.22497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22497</ArticleId><ArticleId IdType="pubmed">23625857</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabrielli M., Raffaele S., Fumagalli M., Verderio C. The multiple faces of extracellular vesicles released by microglia: Where are we 10 years after? Front. Cell. Neurosci. 2022;16:984690. doi: 10.3389/fncel.2022.984690.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2022.984690</ArticleId><ArticleId IdType="pmc">PMC9514840</ArticleId><ArticleId IdType="pubmed">36176630</ArticleId></ArticleIdList></Reference><Reference><Citation>Raffaele S., Lombardi M., Verderio C., Fumagalli M. TNF Production and Release from Microglia via Extracellular Vesicles: Impact on Brain Functions. Cells. 2020;9:2145. doi: 10.3390/cells9102145.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9102145</ArticleId><ArticleId IdType="pmc">PMC7598215</ArticleId><ArticleId IdType="pubmed">32977412</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi P., Turola E., Ruiz A., Bergami A., Libera D.D., Benussi L., Giussani P., Magnani G., Comi G., Legname G., et al. Microglia convert aggregated amyloid-&#x3b2; into neurotoxic forms through the shedding of microvesicles. Cell Death Differ. 2014;21:582&#x2013;593. doi: 10.1038/cdd.2013.180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2013.180</ArticleId><ArticleId IdType="pmc">PMC3950321</ArticleId><ArticleId IdType="pubmed">24336048</ArticleId></ArticleIdList></Reference><Reference><Citation>Verderio C., Muzio L., Turola E., Bergami A., Novellino L., Ruffini F., Riganti L., Corradini I., Francolini M., Garzetti L., et al. Myeloid microvesicles are a marker and therapeutic target for neuroinflammation. Ann. Neurol. 2012;72:610&#x2013;624. doi: 10.1002/ana.23627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23627</ArticleId><ArticleId IdType="pubmed">23109155</ArticleId></ArticleIdList></Reference><Reference><Citation>Aires I.D., Ribeiro-Rodrigues T., Boia R., Ferreira-Rodrigues M., Gir&#xe3;o H., Ambr&#xf3;sio A.F., Santiago A.R. Microglial Extracellular Vesicles as Vehicles for Neurodegeneration Spreading. Biomolecules. 2021;11:770. doi: 10.3390/biom11060770.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11060770</ArticleId><ArticleId IdType="pmc">PMC8224033</ArticleId><ArticleId IdType="pubmed">34063832</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T., Tan X., Li S., Al-Nusaif M., Le W. Role of Glia-Derived Extracellular Vesicles in Neurodegenerative Diseases. Front. Aging Neurosci. 2021;13:765395. doi: 10.3389/fnagi.2021.765395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.765395</ArticleId><ArticleId IdType="pmc">PMC8563578</ArticleId><ArticleId IdType="pubmed">34744700</ArticleId></ArticleIdList></Reference><Reference><Citation>Croese T., Furlan R. Extracellular vesicles in neurodegenerative diseases. Mol. Aspects Med. 2018;60:52&#x2013;61. doi: 10.1016/j.mam.2017.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2017.11.006</ArticleId><ArticleId IdType="pubmed">29137922</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabrielli M., Prada I., Joshi P., Falcicchia C., D&#x2019;Arrigo G., Rutigliano G., Battocchio E., Zenatelli R., Tozzi F., Radeghieri A., et al. Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer&#x2019;s disease. Brain. 2022;145:2849&#x2013;2868. doi: 10.1093/brain/awac083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac083</ArticleId><ArticleId IdType="pmc">PMC9420022</ArticleId><ArticleId IdType="pubmed">35254410</ArticleId></ArticleIdList></Reference><Reference><Citation>Beneventano M., Spampinato S.F., Merlo S., Chisari M., Platania P., Ragusa M., Purrello M., Nicoletti F., Sortino M.A. Shedding of Microvesicles from Microglia Contributes to the Effects Induced by Metabotropic Glutamate Receptor 5 Activation on Neuronal Death. Front. Pharmacol. 2017;8:812. doi: 10.3389/fphar.2017.00812.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2017.00812</ArticleId><ArticleId IdType="pmc">PMC5684115</ArticleId><ArticleId IdType="pubmed">29170640</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.Y., Cui J.G., Dua P., Pogue A.I., Bhattacharjee S., Lukiw W.J. Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells. Neurosci. Lett. 2011;499:109&#x2013;113. doi: 10.1016/j.neulet.2011.05.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2011.05.044</ArticleId><ArticleId IdType="pmc">PMC3713470</ArticleId><ArticleId IdType="pubmed">21640790</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw W.J., Zhao Y., Cui J.G. An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J. Biol. Chem. 2008;283:31315&#x2013;31322. doi: 10.1074/jbc.M805371200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M805371200</ArticleId><ArticleId IdType="pmc">PMC2581572</ArticleId><ArticleId IdType="pubmed">18801740</ArticleId></ArticleIdList></Reference><Reference><Citation>Corps K.N., Roth T.L., McGavern D.B. Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol. 2015;72:355&#x2013;362. doi: 10.1001/jamaneurol.2014.3558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.3558</ArticleId><ArticleId IdType="pmc">PMC5001842</ArticleId><ArticleId IdType="pubmed">25599342</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghajar J. Traumatic brain injury. Lancet. 2000;356:923&#x2013;929. doi: 10.1016/S0140-6736(00)02689-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(00)02689-1</ArticleId><ArticleId IdType="pubmed">11036909</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramlett H.M., Dietrich W.D. Progressive damage after brain and spinal cord injury: Pathomechanisms and treatment strategies. Prog. Brain Res. 2007;161:125&#x2013;141. doi: 10.1016/S0079-6123(06)61009-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0079-6123(06)61009-1</ArticleId><ArticleId IdType="pubmed">17618974</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T., Liu Y.-W., Zhao L., Wang H., Yang N., Dai S.-S., He F. Metabotropic glutamate receptor 5 deficiency inhibits neutrophil infiltration after traumatic brain injury in mice. Sci. Rep. 2017;7:9998. doi: 10.1038/s41598-017-10201-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-10201-8</ArticleId><ArticleId IdType="pmc">PMC5577182</ArticleId><ArticleId IdType="pubmed">28855570</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T., Zhang L., Qu Y., Huo K., Jiang X., Fei Z. The selective mGluR5 agonist CHPG protects against traumatic brain injury in vitro and in vivo via ERK and Akt pathway. Int. J. Mol. Med. 2012;29:630&#x2013;636. doi: 10.3892/ijmm.2011.870.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2011.870</ArticleId><ArticleId IdType="pmc">PMC3577346</ArticleId><ArticleId IdType="pubmed">22211238</ArticleId></ArticleIdList></Reference><Reference><Citation>Ban J., S&#xe1;mano C., Mladinic M., Munitic I. Glia in amyotrophic lateral sclerosis and spinal cord injury: Common therapeutic targets. Croat. Med. J. 2019;60:109&#x2013;120. doi: 10.3325/cmj.2019.60.109.</Citation><ArticleIdList><ArticleId IdType="doi">10.3325/cmj.2019.60.109</ArticleId><ArticleId IdType="pmc">PMC6509626</ArticleId><ArticleId IdType="pubmed">31044582</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdanipour A., Tiraihi T., Taheri T., Kazemi H. Microglial activation in rat experimental spinal cord injury model. Iran. Biomed. J. 2013;17:214&#x2013;220. doi: 10.6091/ibj.1213.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.6091/ibj.1213.2013</ArticleId><ArticleId IdType="pmc">PMC3882925</ArticleId><ArticleId IdType="pubmed">23999718</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills C.D., Fullwood S.D., Hulsebosch C.E. Changes in metabotropic glutamate receptor expression following spinal cord injury. Exp. Neurol. 2001;170:244&#x2013;257. doi: 10.1006/exnr.2001.7721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.2001.7721</ArticleId><ArticleId IdType="pubmed">11476590</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills C.D., Johnson K.M., Hulsebosch C.E. Group I metabotropic glutamate receptors in spinal cord injury: Roles in neuroprotection and the development of chronic central pain. J. Neurotrauma. 2002;19:23&#x2013;42. doi: 10.1089/089771502753460213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/089771502753460213</ArticleId><ArticleId IdType="pubmed">11852976</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrnes K.R., Stoica B., Riccio A., Pajoohesh-Ganji A., Loane D.J., Faden A.I. Activation of metabotropic glutamate receptor 5 improves recovery after spinal cord injury in rodents. Ann. Neurol. 2009;66:63&#x2013;74. doi: 10.1002/ana.21673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21673</ArticleId><ArticleId IdType="pmc">PMC3755738</ArticleId><ArticleId IdType="pubmed">19670441</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolls A., Shechter R., London A., Segev Y., Jacob-Hirsch J., Amariglio N., Rechavi G., Schwartz M. Two faces of chondroitin sulfate proteoglycan in spinal cord repair: A role in microglia/macrophage activation. PLoS Med. 2008;5:e171. doi: 10.1371/journal.pmed.0050171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0050171</ArticleId><ArticleId IdType="pmc">PMC2517615</ArticleId><ArticleId IdType="pubmed">18715114</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallmayer J., Cleveland S., Torres A., Phillips J., Cohen B., Torigoe T., Miller J., Fedele A., Collins J., Smith K., et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch. Gen. Psychiatry. 2011;68:1095&#x2013;1102. doi: 10.1001/archgenpsychiatry.2011.76.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archgenpsychiatry.2011.76</ArticleId><ArticleId IdType="pmc">PMC4440679</ArticleId><ArticleId IdType="pubmed">21727249</ArticleId></ArticleIdList></Reference><Reference><Citation>Zantomio D., Chana G., Laskaris L., Testa R., Everall I., Pantelis C., Skafidas E. Convergent evidence for mGluR5 in synaptic and neuroinflammatory pathways implicated in ASD. Neurosci. Biobehav. Rev. 2015;52:172&#x2013;177. doi: 10.1016/j.neubiorev.2015.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2015.02.006</ArticleId><ArticleId IdType="pubmed">25704074</ArticleId></ArticleIdList></Reference><Reference><Citation>Gipson T.T., Johnston M.V. Plasticity and mTOR: Towards restoration of impaired synaptic plasticity in mTOR-related neurogenetic disorders. Neural Plast. 2012;2012:486402. doi: 10.1155/2012/486402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/486402</ArticleId><ArticleId IdType="pmc">PMC3350854</ArticleId><ArticleId IdType="pubmed">22619737</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong X., Li H., Chang Q. MeCP2 phosphorylation is required for modulating synaptic scaling through mGluR5. J. Neurosci. 2012;32:12841&#x2013;12847. doi: 10.1523/JNEUROSCI.2784-12.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2784-12.2012</ArticleId><ArticleId IdType="pmc">PMC3474205</ArticleId><ArticleId IdType="pubmed">22973007</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaylock R.L., Strunecka A. Immune-glutamatergic dysfunction as a central mechanism of the autism spectrum disorders. Curr. Med. Chem. 2009;16:157&#x2013;170. doi: 10.2174/092986709787002745.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986709787002745</ArticleId><ArticleId IdType="pubmed">19149568</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetreault N.A., Hakeem A.Y., Jiang S., Williams B.A., Allman E., Wold B.J., Allman J.M. Microglia in the cerebral cortex in autism. J. Autism Dev. Disord. 2012;42:2569&#x2013;2584. doi: 10.1007/s10803-012-1513-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10803-012-1513-0</ArticleId><ArticleId IdType="pubmed">22466688</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan J.T., Chana G., Pardo C.A., Achim C., Semendeferi K., Buckwalter J., Courchesne E., Everall I.P. Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol. Psychiatry. 2010;68:368&#x2013;376. doi: 10.1016/j.biopsych.2010.05.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2010.05.024</ArticleId><ArticleId IdType="pubmed">20674603</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 2005;57:67&#x2013;81. doi: 10.1002/ana.20315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20315</ArticleId><ArticleId IdType="pubmed">15546155</ArticleId></ArticleIdList></Reference><Reference><Citation>Toscano C.V.A., Barros L., Lima A.B., Nunes T., Carvalho H.M., Gaspar J.M. Neuroinflammation in autism spectrum disorders: Exercise as a &#x201c;pharmacological&#x201d; tool. Neurosci. Biobehav. Rev. 2021;129:63&#x2013;74. doi: 10.1016/j.neubiorev.2021.07.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2021.07.023</ArticleId><ArticleId IdType="pubmed">34310976</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes H.K., Moreno R.J., Ashwood P. Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD) Brain. Behav. Immun. 2023;108:245&#x2013;254. doi: 10.1016/j.bbi.2022.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.12.001</ArticleId><ArticleId IdType="pubmed">36494048</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta S.M., Hill-Yardin E.L., Crack P.J. The influence of neuroinflammation in Autism Spectrum Disorder. Brain. Behav. Immun. 2019;79:75&#x2013;90. doi: 10.1016/j.bbi.2019.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2019.04.037</ArticleId><ArticleId IdType="pubmed">31029798</ArticleId></ArticleIdList></Reference><Reference><Citation>Gai X., Xie H.M., Perin J.C., Takahashi N., Murphy K., Wenocur A.S., D&#x2019;arcy M., O&#x2019;Hara R.J., Goldmuntz E., Grice D.E., et al. Rare structural variation of synapse and neurotransmission genes in autism. Mol. Psychiatry. 2012;17:402&#x2013;411. doi: 10.1038/mp.2011.10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2011.10</ArticleId><ArticleId IdType="pmc">PMC3314176</ArticleId><ArticleId IdType="pubmed">21358714</ArticleId></ArticleIdList></Reference><Reference><Citation>Verpelli C., Dvoretskova E., Vicidomini C., Rossi F., Chiappalone M., Schoen M., Di Stefano B., Mantegazza R., Broccoli V., B&#xf6;ckers T.M., et al. Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses. J. Biol. Chem. 2011;286:34839&#x2013;34850. doi: 10.1074/jbc.M111.258384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.258384</ArticleId><ArticleId IdType="pmc">PMC3186429</ArticleId><ArticleId IdType="pubmed">21795692</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y., Du Y., Chen L., Liu Y., Xu W., Liu Y., Li Y., Leng J., Wang Y., Zhang X.-Y., et al. A recurrent SHANK1 mutation implicated in autism spectrum disorder causes autistic-like core behaviors in mice via downregulation of mGluR1-IP3R1-calcium signaling. Mol. Psychiatry. 2022;27:2985&#x2013;2998. doi: 10.1038/s41380-022-01539-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01539-1</ArticleId><ArticleId IdType="pmc">PMC9205781</ArticleId><ArticleId IdType="pubmed">35388181</ArticleId></ArticleIdList></Reference><Reference><Citation>Chana G., Laskaris L., Pantelis C., Gillett P., Testa R., Zantomio D., Burrows E.L., Hannan A.J., Everall I.P., Skafidas E. Decreased expression of mGluR5 within the dorsolateral prefrontal cortex in autism and increased microglial number in mGluR5 knockout mice: Pathophysiological and neurobehavioral implications. Brain. Behav. Immun. 2015;49:197&#x2013;205. doi: 10.1016/j.bbi.2015.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.05.009</ArticleId><ArticleId IdType="pubmed">26052099</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricciardi S., Boggio E.M., Grosso S., Lonetti G., Forlani G., Stefanelli G., Calcagno E., Morello N., Landsberger N., Biffo S., et al. Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. Hum. Mol. Genet. 2011;20:1182&#x2013;1196. doi: 10.1093/hmg/ddq563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq563</ArticleId><ArticleId IdType="pubmed">21212100</ArticleId></ArticleIdList></Reference><Reference><Citation>Pecorelli A., Cervellati C., Cordone V., Hayek J., Valacchi G. Compromised immune/inflammatory responses in Rett syndrome. Free Radic. Biol. Med. 2020;152:100&#x2013;106. doi: 10.1016/j.freeradbiomed.2020.02.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2020.02.023</ArticleId><ArticleId IdType="pubmed">32119978</ArticleId></ArticleIdList></Reference><Reference><Citation>Maezawa I., Jin L.-W. Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J. Neurosci. 2010;30:5346&#x2013;5356. doi: 10.1523/JNEUROSCI.5966-09.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5966-09.2010</ArticleId><ArticleId IdType="pmc">PMC5533099</ArticleId><ArticleId IdType="pubmed">20392956</ArticleId></ArticleIdList></Reference><Reference><Citation>Derecki N.C., Cronk J.C., Kipnis J. The role of microglia in brain maintenance: Implications for Rett syndrome. Trends Immunol. 2013;34:144&#x2013;150. doi: 10.1016/j.it.2012.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2012.10.002</ArticleId><ArticleId IdType="pmc">PMC3566274</ArticleId><ArticleId IdType="pubmed">23122051</ArticleId></ArticleIdList></Reference><Reference><Citation>Gogliotti R.G., Senter R.K., Rook J.M., Ghoshal A., Zamorano R., Malosh C., Stauffer S.R., Bridges T.M., Bartolome J.M., Daniels J.S., et al. mGlu5 positive allosteric modulation normalizes synaptic plasticity defects and motor phenotypes in a mouse model of Rett syndrome. Hum. Mol. Genet. 2016;25:1990&#x2013;2004. doi: 10.1093/hmg/ddw074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw074</ArticleId><ArticleId IdType="pmc">PMC5062588</ArticleId><ArticleId IdType="pubmed">26936821</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao J., Wu H., Coronado A.A., de Laittre E., Osterweil E.K., Zhang Y., Bear M.F. Negative Allosteric Modulation of mGluR5 Partially Corrects Pathophysiology in a Mouse Model of Rett Syndrome. J. Neurosci. Off. J. Soc. Neurosci. 2016;36:11946&#x2013;11958. doi: 10.1523/JNEUROSCI.0672-16.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0672-16.2016</ArticleId><ArticleId IdType="pmc">PMC5125247</ArticleId><ArticleId IdType="pubmed">27881780</ArticleId></ArticleIdList></Reference><Reference><Citation>Cusick M.F., Libbey J.E., Patel D.C., Doty D.J., Fujinami R.S. Infiltrating macrophages are key to the development of seizures following virus infection. J. Virol. 2013;87:1849&#x2013;1860. doi: 10.1128/JVI.02747-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02747-12</ArticleId><ArticleId IdType="pmc">PMC3554195</ArticleId><ArticleId IdType="pubmed">23236075</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkman N.J., Libbey J.E., Wilcox K.S., White H.S., Fujinami R.S. Innate but not adaptive immune responses contribute to behavioral seizures following viral infection. Epilepsia. 2010;51:454&#x2013;464. doi: 10.1111/j.1528-1167.2009.02390.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1528-1167.2009.02390.x</ArticleId><ArticleId IdType="pmc">PMC3046460</ArticleId><ArticleId IdType="pubmed">19845729</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel D.C., Wallis G., Dahle E.J., McElroy P.B., Thomson K.E., Tesi R.J., Szymkowski D.E., West P.J., Smeal R.M., Patel M., et al. Hippocampal TNF&#x3b1; Signaling Contributes to Seizure Generation in an Infection-Induced Mouse Model of Limbic Epilepsy. eNeuro. 2017;4:ENEURO.0105-17.2017. doi: 10.1523/ENEURO.0105-17.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/ENEURO.0105-17.2017</ArticleId><ArticleId IdType="pmc">PMC5422919</ArticleId><ArticleId IdType="pubmed">28497109</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauletti A., Terrone G., Shekh-Ahmad T., Salamone A., Ravizza T., Rizzi M., Pastore A., Pascente R., Liang L.-P., Villa B.R., et al. Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy. Brain. 2017;140:1885&#x2013;1899. doi: 10.1093/brain/awz130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz130</ArticleId><ArticleId IdType="pmc">PMC6248577</ArticleId><ArticleId IdType="pubmed">28575153</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertani I., Iori V., Trusel M., Maroso M., Foray C., Mantovani S., Tonini R., Vezzani A., Chiesa R. Inhibition of IL-1&#x3b2; Signaling Normalizes NMDA-Dependent Neurotransmission and Reduces Seizure Susceptibility in a Mouse Model of Creutzfeldt-Jakob Disease. J. Neurosci. 2017;37:10278&#x2013;10289. doi: 10.1523/JNEUROSCI.1301-17.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1301-17.2017</ArticleId><ArticleId IdType="pmc">PMC6596629</ArticleId><ArticleId IdType="pubmed">28924012</ArticleId></ArticleIdList></Reference><Reference><Citation>Vezzani A., Lang B., Aronica E. Immunity and Inflammation in Epilepsy. Cold Spring Harb. Perspect. Med. 2015;6:a022699. doi: 10.1101/cshperspect.a022699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a022699</ArticleId><ArticleId IdType="pmc">PMC4743070</ArticleId><ArticleId IdType="pubmed">26684336</ArticleId></ArticleIdList></Reference><Reference><Citation>Howe C.L., Lafrance-Corey R.G., Sundsbak R.S., Lafrance S.J. Inflammatory monocytes damage the hippocampus during acute picornavirus infection of the brain. J. Neuroinflamm. 2012;9:50. doi: 10.1186/1742-2094-9-50.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-9-50</ArticleId><ArticleId IdType="pmc">PMC3368782</ArticleId><ArticleId IdType="pubmed">22405261</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z.-Y., Sun B.-L., Liu J.-K., Yang M.-F., Li D.-W., Fang J., Zhang S., Yuan Q.-L., Huang S.-L. Activation of mGluR5 Attenuates Microglial Activation and Neuronal Apoptosis in Early Brain Injury After Experimental Subarachnoid Hemorrhage in Rats. Neurochem. Res. 2015;40:1121&#x2013;1132. doi: 10.1007/s11064-015-1572-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-015-1572-7</ArticleId><ArticleId IdType="pubmed">25846008</ArticleId></ArticleIdList></Reference><Reference><Citation>Manno E.M. Update on intracerebral hemorrhage. Continuum. 2012;18:598&#x2013;610. doi: 10.1212/01.CON.0000415430.99394.3e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.CON.0000415430.99394.3e</ArticleId><ArticleId IdType="pubmed">22810251</ArticleId></ArticleIdList></Reference><Reference><Citation>Broderick J.P., Brott T.G., Duldner J.E., Tomsick T., Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987&#x2013;993. doi: 10.1161/01.STR.24.7.987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.24.7.987</ArticleId><ArticleId IdType="pubmed">8322400</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo E.H., Dalkara T., Moskowitz M.A. Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 2003;4:399&#x2013;415. doi: 10.1038/nrn1106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1106</ArticleId><ArticleId IdType="pubmed">12728267</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan X., Han X., Li Q., Yang Q.-W., Wang J. Modulators of microglial activation and polarization after intracerebral haemorrhage. Nat. Rev. Neurol. 2017;13:420&#x2013;433. doi: 10.1038/nrneurol.2017.69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2017.69</ArticleId><ArticleId IdType="pmc">PMC5575938</ArticleId><ArticleId IdType="pubmed">28524175</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Zhang Z., Lu H., Yang Q., Wu H., Wang J. Microglial Polarization and Inflammatory Mediators After Intracerebral Hemorrhage. Mol. Neurobiol. 2017;54:1874&#x2013;1886. doi: 10.1007/s12035-016-9785-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-9785-6</ArticleId><ArticleId IdType="pmc">PMC4991954</ArticleId><ArticleId IdType="pubmed">26894396</ArticleId></ArticleIdList></Reference><Reference><Citation>Barres B.A. The Mystery and Magic of Glia: A Perspective on Their Roles in Health and Disease. Neuron. 2008;60:430&#x2013;440. doi: 10.1016/j.neuron.2008.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2008.10.013</ArticleId><ArticleId IdType="pubmed">18995817</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh M.-H., Ho S.-C., Yeh K.-Y., Pawlak C.R., Chang H.-M., Ho Y.-J., Lai T.-J., Wu F.-Y. Blockade of metabotropic glutamate receptors inhibits cognition and neurodegeneration in an MPTP-induced Parkinson&#x2019;s disease rat model. Pharmacol. Biochem. Behav. 2012;102:64&#x2013;71. doi: 10.1016/j.pbb.2012.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbb.2012.03.022</ArticleId><ArticleId IdType="pubmed">22487770</ArticleId></ArticleIdList></Reference><Reference><Citation>Makarewicz D., Duszczyk M., Gadamski R., Danysz W., &#x141;azarewicz J.W. Neuroprotective potential of group I metabotropic glutamate receptor antagonists in two ischemic models. Neurochem. Int. 2006;48:485&#x2013;490. doi: 10.1016/j.neuint.2005.12.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2005.12.022</ArticleId><ArticleId IdType="pubmed">16513218</ArticleId></ArticleIdList></Reference><Reference><Citation>Abushik P.A., Niittykoski M., Giniatullina R., Shakirzyanova A., Bart G., Fayuk D., Sibarov D.A., Antonov S.M., Giniatullin R. The role of NMDA and mGluR5 receptors in calcium mobilization and neurotoxicity of homocysteine in trigeminal and cortical neurons and glial cells. J. Neurochem. 2014;129:264&#x2013;274. doi: 10.1111/jnc.12615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12615</ArticleId><ArticleId IdType="pubmed">24266734</ArticleId></ArticleIdList></Reference><Reference><Citation>Overk C.R., Cartier A., Shaked G., Rockenstein E., Ubhi K., Spencer B., Price D.L., Patrick C., Desplats P., Masliah E. Hippocampal neuronal cells that accumulate &#x3b1;-synuclein fragments are more vulnerable to A&#x3b2; oligomer toxicity via mGluR5--implications for dementia with Lewy bodies. Mol. Neurodegener. 2014;9:18. doi: 10.1186/1750-1326-9-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-9-18</ArticleId><ArticleId IdType="pmc">PMC4041038</ArticleId><ArticleId IdType="pubmed">24885390</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman M.S., Yang J., Luan Y., Qiu Z., Zhang J., Lu H., Chen X., Liu Y. Attenuation of Acute Intracerebral Hemorrhage-Induced Microglial Activation and Neuronal Death Mediated by the Blockade of Metabotropic Glutamate Receptor 5 In Vivo. Neurochem. Res. 2020;45:1230&#x2013;1243. doi: 10.1007/s11064-020-03006-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-020-03006-1</ArticleId><ArticleId IdType="pubmed">32140955</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Zhang N., Sun G., Ding S. Inhibition of the group I mGluRs reduces acute brain damage and improves long-term histological outcomes after photothrombosis-induced ischaemia. ASN Neuro. 2013;5:195&#x2013;207. doi: 10.1042/AN20130002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/AN20130002</ArticleId><ArticleId IdType="pmc">PMC3786425</ArticleId><ArticleId IdType="pubmed">23772679</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao W.L., Williams A.J., Faden A.I., Tortella F.C. Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia. Brain Res. 2001;922:173&#x2013;179. doi: 10.1016/S0006-8993(01)03062-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(01)03062-1</ArticleId><ArticleId IdType="pubmed">11743947</ArticleId></ArticleIdList></Reference><Reference><Citation>Szydlowska K., Kaminska B., Baude A., Parsons C.G., Danysz W. Neuroprotective activity of selective mGlu1 and mGlu5 antagonists in vitro and in vivo. Eur. J. Pharmacol. 2007;554:18&#x2013;29. doi: 10.1016/j.ejphar.2006.09.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2006.09.061</ArticleId><ArticleId IdType="pubmed">17109843</ArticleId></ArticleIdList></Reference><Reference><Citation>Law H.C.H., Szeto S.S.W., Quan Q., Zhao Y., Zhang Z., Krakovska O., Lui L.T., Zheng C., Lee S.M.-Y., Siu K.W.M., et al. Characterization of the Molecular Mechanisms Underlying the Chronic Phase of Stroke in a Cynomolgus Monkey Model of Induced Cerebral Ischemia. J. Proteome Res. 2017;16:1150&#x2013;1166. doi: 10.1021/acs.jproteome.6b00651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.6b00651</ArticleId><ArticleId IdType="pubmed">28102082</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchan A.M., Pulsinelli W.A. Septo-hippocampal deafferentation protects CA1 neurons against ischemic injury. Brain Res. 1990;512:7&#x2013;14. doi: 10.1016/0006-8993(90)91163-B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(90)91163-B</ArticleId><ArticleId IdType="pubmed">2337809</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyot L.L., Diaz F.G., O&#x2019;Regan M.H., Song D., Phillis J.W. The effect of streptozotocin-induced diabetes on the release of excitotoxic and other amino acids from the ischemic rat cerebral cortex. Neurosurgery. 2001;48:381&#x2013;385. doi: 10.1097/00006123-200102000-00030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006123-200102000-00030</ArticleId><ArticleId IdType="pubmed">11220383</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreeva K., Zhang M., Fan W., Li X., Chen Y., Rebolledo-Mendez J.D., Cooper N.G. Time-dependent Gene Profiling Indicates the Presence of Different Phases for Ischemia/Reperfusion Injury in Retina. Ophthalmol. Eye Dis. 2014;6:43&#x2013;54. doi: 10.4137/OED.S17671.</Citation><ArticleIdList><ArticleId IdType="doi">10.4137/OED.S17671</ArticleId><ArticleId IdType="pmc">PMC4149383</ArticleId><ArticleId IdType="pubmed">25210480</ArticleId></ArticleIdList></Reference><Reference><Citation>Du C., Hu R., Csernansky C.A., Liu X.Z., Hsu C.Y., Choi D.W. Additive neuroprotective effects of dextrorphan and cycloheximide in rats subjected to transient focal cerebral ischemia. Brain Res. 1996;718:233&#x2013;236. doi: 10.1016/0006-8993(96)00162-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(96)00162-X</ArticleId><ArticleId IdType="pubmed">8773794</ArticleId></ArticleIdList></Reference><Reference><Citation>Wetterling F., Chatzikonstantinou E., Tritschler L., Meairs S., Fatar M., Schad L.R., Ansar S. Investigating potentially salvageable penumbra tissue in an in vivo model of transient ischemic stroke using sodium, diffusion, and perfusion magnetic resonance imaging. BMC Neurosci. 2016;17:82. doi: 10.1186/s12868-016-0316-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12868-016-0316-1</ArticleId><ArticleId IdType="pmc">PMC5143461</ArticleId><ArticleId IdType="pubmed">27927188</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb M., Matute C. Expression of ionotropic glutamate receptor subunits in glial cells of the hippocampal CA1 area following transient forebrain ischemia. J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab. 1997;17:290&#x2013;300. doi: 10.1097/00004647-199703000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004647-199703000-00006</ArticleId><ArticleId IdType="pubmed">9119902</ArticleId></ArticleIdList></Reference><Reference><Citation>Domercq M., S&#xe1;nchez-G&#xf3;mez M.V., Sherwin C., Etxebarria E., Fern R., Matute C. System xc- and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes. J. Immunol. 2007;178:6549&#x2013;6556. doi: 10.4049/jimmunol.178.10.6549.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.178.10.6549</ArticleId><ArticleId IdType="pubmed">17475885</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Zhang M., Yang S.-D., Li W.-B., Ren S.-Q., Zhang J., Zhang F. Pre-ischemic treadmill training alleviates brain damage via GLT-1-mediated signal pathway after ischemic stroke in rats. Neuroscience. 2014;274:393&#x2013;402. doi: 10.1016/j.neuroscience.2014.05.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2014.05.053</ArticleId><ArticleId IdType="pubmed">24907601</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Wu Y., Jia J., Hu Y.-S. Pre-ischemic treadmill training induces tolerance to brain ischemia: Involvement of glutamate and ERK1/2. Molecules. 2010;15:5246&#x2013;5257. doi: 10.3390/molecules15085246.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules15085246</ArticleId><ArticleId IdType="pmc">PMC6257775</ArticleId><ArticleId IdType="pubmed">20714296</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavallo D., Landucci E., Gerace E., Lana D., Ugolini F., Henley J.M., Giovannini M.G., Pellegrini-Giampietro D.E. Neuroprotective effects of mGluR5 activation through the PI3K/Akt pathway and the molecular switch of AMPA receptors. Neuropharmacology. 2020;162:107810. doi: 10.1016/j.neuropharm.2019.107810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2019.107810</ArticleId><ArticleId IdType="pubmed">31600563</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini-Giampietro D.E. The distinct role of mGlu1 receptors in post-ischemic neuronal death. Trends Pharmacol. Sci. 2003;24:461&#x2013;470. doi: 10.1016/S0165-6147(03)00231-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-6147(03)00231-1</ArticleId><ArticleId IdType="pubmed">12967771</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar G.M., Li S., Mehta T.H., Garcia-Munoz A., Shepardson N.E., Smith I., Brett F.M., Farrell M.A., Rowan M.J., Lemere C.A., et al. Amyloid-beta protein dimers isolated directly from Alzheimer&#x2019;s brains impair synaptic plasticity and memory. Nat. Med. 2008;14:837&#x2013;842. doi: 10.1038/nm1782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1782</ArticleId><ArticleId IdType="pmc">PMC2772133</ArticleId><ArticleId IdType="pubmed">18568035</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolicelli R.C., Bolasco G., Pagani F., Maggi L., Scianni M., Panzanelli P., Giustetto M., Ferreira T.A., Guiducci E., Dumas L., et al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011;333:1456&#x2013;1458. doi: 10.1126/science.1202529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1202529</ArticleId><ArticleId IdType="pubmed">21778362</ArticleId></ArticleIdList></Reference><Reference><Citation>Kettenmann H., Kirchhoff F., Verkhratsky A. Microglia: New roles for the synaptic stripper. Neuron. 2013;77:10&#x2013;18. doi: 10.1016/j.neuron.2012.12.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2012.12.023</ArticleId><ArticleId IdType="pubmed">23312512</ArticleId></ArticleIdList></Reference><Reference><Citation>Bie B., Wu J., Yang H., Xu J.J., Brown D.L., Naguib M. Epigenetic suppression of neuroligin 1 underlies amyloid-induced memory deficiency. Nat. Neurosci. 2014;17:223&#x2013;231. doi: 10.1038/nn.3618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3618</ArticleId><ArticleId IdType="pubmed">24441681</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan Y., Paolicelli R.C., Sforazzini F., Weinhard L., Bolasco G., Pagani F., Vyssotski A.L., Bifone A., Gozzi A., Ragozzino D., et al. Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior. Nat. Neurosci. 2014;17:400&#x2013;406. doi: 10.1038/nn.3641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3641</ArticleId><ArticleId IdType="pubmed">24487234</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashley C.T.J., Wilkinson K.D., Reines D., Warren S.T. FMR1 protein: Conserved RNP family domains and selective RNA binding. Science. 1993;262:563&#x2013;566. doi: 10.1126/science.7692601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.7692601</ArticleId><ArticleId IdType="pubmed">7692601</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassell G.J., Warren S.T. Fragile X syndrome: Loss of local mRNA regulation alters synaptic development and function. Neuron. 2008;60:201&#x2013;214. doi: 10.1016/j.neuron.2008.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2008.10.004</ArticleId><ArticleId IdType="pmc">PMC3691995</ArticleId><ArticleId IdType="pubmed">18957214</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton A., Zamponi G.W., Ferguson S.S.G. Glutamate receptors function as scaffolds for the regulation of &#x3b2;-amyloid and cellular prion protein signaling complexes. Mol. Brain. 2015;8:18. doi: 10.1186/s13041-015-0107-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-015-0107-0</ArticleId><ArticleId IdType="pmc">PMC4395978</ArticleId><ArticleId IdType="pubmed">25888324</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui H., Zhang J., Makinson S.R., Cahill M.K., Kelley K.W., Huang H.-Y., Shang Y., Oldham M.C., Martens L.H., Gao F., et al. Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation. Cell. 2016;165:921&#x2013;935. doi: 10.1016/j.cell.2016.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.04.001</ArticleId><ArticleId IdType="pmc">PMC4860138</ArticleId><ArticleId IdType="pubmed">27114033</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephan A.H., Barres B.A., Stevens B. The complement system: An unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci. 2012;35:369&#x2013;389. doi: 10.1146/annurev-neuro-061010-113810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-neuro-061010-113810</ArticleId><ArticleId IdType="pubmed">22715882</ArticleId></ArticleIdList></Reference><Reference><Citation>Bie B., Wu J., Foss J.F., Naguib M. Activation of mGluR1 Mediates C1q-Dependent Microglial Phagocytosis of Glutamatergic Synapses in Alzheimer&#x2019;s Rodent Models. Mol. Neurobiol. 2019;56:5568&#x2013;5585. doi: 10.1007/s12035-019-1467-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1467-8</ArticleId><ArticleId IdType="pmc">PMC6615956</ArticleId><ArticleId IdType="pubmed">30652266</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S., Beja-Glasser V.F., Nfonoyim B.M., Frouin A., Li S., Ramakrishnan S., Merry K.M., Shi Q., Rosenthal A., Barres B.A., et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352:712&#x2013;716. doi: 10.1126/science.aad8373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad8373</ArticleId><ArticleId IdType="pmc">PMC5094372</ArticleId><ArticleId IdType="pubmed">27033548</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Prisco G.V., Huang W., Buffington S.A., Hsu C.-C., Bonnen P.E., Placzek A.N., Sidrauski C., Krnjevi&#x107; K., Kaufman R.J., Walter P., et al. Translational control of mGluR-dependent long-term depression and object-place learning by eIF2&#x3b1;. Nat. Neurosci. 2014;17:1073&#x2013;1082. doi: 10.1038/nn.3754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3754</ArticleId><ArticleId IdType="pmc">PMC4340591</ArticleId><ArticleId IdType="pubmed">24974795</ArticleId></ArticleIdList></Reference><Reference><Citation>Spurrier J., Nicholson L., Fang X.T., Stoner A.J., Toyonaga T., Holden D., Siegert T.R., Laird W., Allnutt M.A., Chiasseu M., et al. Reversal of synapse loss in Alzheimer mouse models by targeting mGluR5 to prevent synaptic tagging by C1Q. Sci. Transl. Med. 2022;14:eabi8593. doi: 10.1126/scitranslmed.abi8593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abi8593</ArticleId><ArticleId IdType="pmc">PMC9554345</ArticleId><ArticleId IdType="pubmed">35648810</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chi&#xf2; A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Publ. Gr. 2013;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland L.P., Shneider N.A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacino T., Zerbo R.A., Balbi M., Torazza C., Frumento G., Fedele E., Bonanno G., Milanese M. Nearly 30 Years of Animal Models to Study Amyotrophic Lateral Sclerosis: A Historical Overview and Future Perspectives. Int. J. Mol. Sci. 2021;22:12236. doi: 10.3390/ijms222212236.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222212236</ArticleId><ArticleId IdType="pmc">PMC8619465</ArticleId><ArticleId IdType="pubmed">34830115</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.C.A., Flynn H., Adamson J., et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Sim&#xf3;n-S&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J.J., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucchia M., Ramirez A., Parente V., Simone C., Nizzardo M., Magri F., Dametti S., Corti S. Therapeutic development in amyotrophic lateral sclerosis. Clin. Ther. 2015;37:668&#x2013;680. doi: 10.1016/j.clinthera.2014.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2014.12.020</ArticleId><ArticleId IdType="pubmed">25666449</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.G., Mitchell J.D., Moore D.H. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) Cochrane Database Syst. Rev. 2012;2012:CD001447. doi: 10.1002/14651858.CD001447.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001447.pub3</ArticleId><ArticleId IdType="pubmed">11687111</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada M., Yamashita S., Ueyama H., Ishizaki M., Maeda Y., Ando Y. Long-term effects of edaravone on survival of patients with amyotrophic lateral sclerosis. eNeurologicalSci. 2018;11:11&#x2013;14. doi: 10.1016/j.ensci.2018.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ensci.2018.05.001</ArticleId><ArticleId IdType="pmc">PMC6006910</ArticleId><ArticleId IdType="pubmed">29928711</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K., Aoki M., Tsuji S., Itoyama Y., Sobue G., Togo M., Hamada C., Tanaka M., Akimoto M., Nakamura K., et al. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16:505&#x2013;512. doi: 10.1016/S1474-4422(17)30115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M., Wuu J., Andersen P.M., Bucelli R.C., Andrews J.A., Otto M., Farahany N.A., Harrington E.A., Chen W., Mitchell A.A., et al. Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: The ATLAS Study. Neurother. J. Am. Soc. Exp. Neurother. 2022;19:1686. doi: 10.1007/s13311-022-01286-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-022-01286-9</ArticleId><ArticleId IdType="pmc">PMC9587202</ArticleId><ArticleId IdType="pubmed">35585374</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Harten A.C.M.M., Phatnani H., Przedborski S. Non-cell-autonomous pathogenic mechanisms in amyotrophic lateral sclerosis. Trends Neurosci. 2021;44:658&#x2013;668. doi: 10.1016/j.tins.2021.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2021.04.008</ArticleId><ArticleId IdType="pmc">PMC8972039</ArticleId><ArticleId IdType="pubmed">34006386</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Acioglu C., Heary R.F., Elkabes S. Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases. Brain. Behav. Immun. 2021;91:740&#x2013;755. doi: 10.1016/j.bbi.2020.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.10.007</ArticleId><ArticleId IdType="pmc">PMC7543714</ArticleId><ArticleId IdType="pubmed">33039660</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C., Yousefian-Jazi A., Choi S.-H., Chang I., Lee J., Ryu H. Non-Cell Autonomous and Epigenetic Mechanisms of Huntington&#x2019;s Disease. Int. J. Mol. Sci. 2021;22:12499. doi: 10.3390/ijms222212499.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222212499</ArticleId><ArticleId IdType="pmc">PMC8617801</ArticleId><ArticleId IdType="pubmed">34830381</ArticleId></ArticleIdList></Reference><Reference><Citation>Seol Y., Ki S., Ryu H.L., Chung S., Lee J., Ryu H. How Microglia Manages Non-cell Autonomous Vicious Cycling of A&#x3b2; Toxicity in the Pathogenesis of AD. Front. Mol. Neurosci. 2020;13:593724. doi: 10.3389/fnmol.2020.593724.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.593724</ArticleId><ArticleId IdType="pmc">PMC7718019</ArticleId><ArticleId IdType="pubmed">33328884</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S., Kim H.-J., Kim D.-K., Lee S.-J. Non-cell-autonomous actions of &#x3b1;-synuclein: Implications in glial synucleinopathies. Prog. Neurobiol. 2018;169:158&#x2013;171. doi: 10.1016/j.pneurobio.2018.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2018.06.010</ArticleId><ArticleId IdType="pubmed">30173732</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H., Polymenidou M., Cleveland D.W. Non&#x2013;cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 2009;187:761&#x2013;772. doi: 10.1083/jcb.200908164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908164</ArticleId><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaz S.H., Pinto S., Sebasti&#xe3;o A.M., Brites D. In: Astrocytes in Amyotrophic Lateral Sclerosis. Araki T., editor. Exon Publications; Brisbane, Australia: 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">34473439</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer P.L., McGeer E.G. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve. 2002;26:459&#x2013;470. doi: 10.1002/mus.10191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10191</ArticleId><ArticleId IdType="pubmed">12362410</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers D.R., Henkel J.S., Xiao Q., Zhao W., Wang J., Yen A.A., Siklos L., McKercher S.R., Appel S.H. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2006;103:16021&#x2013;16026. doi: 10.1073/pnas.0607423103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0607423103</ArticleId><ArticleId IdType="pmc">PMC1613228</ArticleId><ArticleId IdType="pubmed">17043238</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers D.R., Henkel J.S., Zhao W., Wang J., Appel S.H. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc. Natl. Acad. Sci. USA. 2008;105:15558&#x2013;15563. doi: 10.1073/pnas.0807419105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0807419105</ArticleId><ArticleId IdType="pmc">PMC2547419</ArticleId><ArticleId IdType="pubmed">18809917</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu I.M., Phatnani H., Kuligowski M., Tapia J.C., Carrasco M.A., Zhang M., Maniatis T., Carroll M.C. Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. Proc. Natl. Acad. Sci. USA. 2009;106:20960&#x2013;20965. doi: 10.1073/pnas.0911405106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0911405106</ArticleId><ArticleId IdType="pmc">PMC2791631</ArticleId><ArticleId IdType="pubmed">19933335</ArticleId></ArticleIdList></Reference><Reference><Citation>Lincecum J.M., Vieira F.G., Wang M.Z., Thompson K., De Zutter G.S., Kidd J., Moreno A., Sanchez R., Carrion I.J., Levine B.A., et al. From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis. Nat. Genet. 2010;42:392&#x2013;399. doi: 10.1038/ng.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.557</ArticleId><ArticleId IdType="pubmed">20348957</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Rothstein J.D. Glial cells in amyotrophic lateral sclerosis. Exp. Neurol. 2014;262:111&#x2013;120. doi: 10.1016/j.expneurol.2014.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.05.015</ArticleId><ArticleId IdType="pmc">PMC4241182</ArticleId><ArticleId IdType="pubmed">24859452</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Beers D.R., Hooten K.G., Sieglaff D.H., Zhang A., Kalyana-Sundaram S., Traini C.M., Halsey W.S., Hughes A.M., Sathe G.M., et al. Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes Supplemental content. JAMA Neurol. 2017;74:677&#x2013;685. doi: 10.1001/jamaneurol.2017.0357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.0357</ArticleId><ArticleId IdType="pmc">PMC5822209</ArticleId><ArticleId IdType="pubmed">28437540</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers D.R., Appel S.H. Immune dysregulation in amyotrophic lateral sclerosis: Mechanisms and emerging therapies. Lancet Neurol. 2019;18:211&#x2013;220. doi: 10.1016/S1474-4422(18)30394-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30394-6</ArticleId><ArticleId IdType="pubmed">30663610</ArticleId></ArticleIdList></Reference><Reference><Citation>Becher B., Spath S., Goverman J. Cytokine networks in neuroinflammation. Nat. Rev. Immunol. 2017;17:49&#x2013;59. doi: 10.1038/nri.2016.123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.123</ArticleId><ArticleId IdType="pubmed">27916979</ArticleId></ArticleIdList></Reference><Reference><Citation>Brites D., Vaz A.R. Microglia centered pathogenesis in ALS: Insights in cell interconnectivity. Front. Cell. Neurosci. 2014;8:117. doi: 10.3389/fncel.2014.00117.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00117</ArticleId><ArticleId IdType="pmc">PMC4033073</ArticleId><ArticleId IdType="pubmed">24904276</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerber Y.N., Sabourin J.C., Hugnot J.P., Perrin F.E. Unlike Physical Exercise, Modified Environment Increases the Lifespan of SOD1G93A Mice However Both Conditions Induce Cellular Changes. PLoS ONE. 2012;7:e45503. doi: 10.1371/journal.pone.0045503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0045503</ArticleId><ArticleId IdType="pmc">PMC3447796</ArticleId><ArticleId IdType="pubmed">23029057</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexianu M.E., Kozovska M., Appel S.H. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology. 2001;57:1282&#x2013;1289. doi: 10.1212/WNL.57.7.1282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.57.7.1282</ArticleId><ArticleId IdType="pubmed">11591849</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka M.T., Kummer M.P., Latz E. Innate immune activation in neurodegenerative disease. Nat. Rev. Immunol. 2014;14:463&#x2013;477. doi: 10.1038/nri3705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3705</ArticleId><ArticleId IdType="pubmed">24962261</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers D.R., Zhao W., Liao B., Kano O., Wang J., Huang A., Appel S.H., Henkel J.S. Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice. Brain. Behav. Immun. 2011;25:1025&#x2013;1035. doi: 10.1016/j.bbi.2010.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2010.12.008</ArticleId><ArticleId IdType="pmc">PMC3096756</ArticleId><ArticleId IdType="pubmed">21176785</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis C.-A., Manning J., Rossi F., Krieger C. The Neuroinflammatory Response in ALS: The Roles of Microglia and T Cells. Neurol. Res. Int. 2012;2012:803701. doi: 10.1155/2012/803701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/803701</ArticleId><ArticleId IdType="pmc">PMC3362167</ArticleId><ArticleId IdType="pubmed">22666587</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R.A., Ansorge O., Strong M., Bilbao J., Zinman L., Ang L.-C., Baker M., Stewart H., Eisen A., Rademakers R., et al. Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: Two distinct patterns correlating with disease severity and mutation. Acta Neuropathol. 2011;122:87&#x2013;98. doi: 10.1007/s00401-011-0838-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0838-7</ArticleId><ArticleId IdType="pmc">PMC3319073</ArticleId><ArticleId IdType="pubmed">21604077</ArticleId></ArticleIdList></Reference><Reference><Citation>Karki P., Smith K., Johnson J., Lee E. Astrocyte-derived growth factors and estrogen neuroprotection: Role of transforming growth factor-$&#x3b1;$ in estrogen-induced upregulation of glutamate transporters in astrocytes. Mol. Cell. Endocrinol. 2014;389:58&#x2013;64. doi: 10.1016/j.mce.2014.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2014.01.010</ArticleId><ArticleId IdType="pmc">PMC4040305</ArticleId><ArticleId IdType="pubmed">24447465</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonfanti E., Bonifacino T., Raffaele S., Milanese M., Morgante E., Bonanno G., Abbracchio M.P., Fumagalli M. Abnormal upregulation of gpr17 receptor contributes to oligodendrocyte dysfunction in SOD1G93A mice. Int. J. Mol. Sci. 2020;21:2395. doi: 10.3390/ijms21072395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21072395</ArticleId><ArticleId IdType="pmc">PMC7177925</ArticleId><ArticleId IdType="pubmed">32244295</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickman S.E., Allison E.K., El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer&#x2019;s disease mice. J. Neurosci. 2008;28:8354&#x2013;8360. doi: 10.1523/JNEUROSCI.0616-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0616-08.2008</ArticleId><ArticleId IdType="pmc">PMC2597474</ArticleId><ArticleId IdType="pubmed">18701698</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelucci A., Heurtaux T., Grandbarbe L., Morga E., Heuschling P. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-beta. J. Neuroimmunol. 2009;210:3&#x2013;12. doi: 10.1016/j.jneuroim.2009.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2009.02.003</ArticleId><ArticleId IdType="pubmed">19269040</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao B., Zhao W., Beers D.R., Henkel J.S., Appel S.H. Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Exp. Neurol. 2012;237:147&#x2013;152. doi: 10.1016/j.expneurol.2012.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2012.06.011</ArticleId><ArticleId IdType="pmc">PMC4126417</ArticleId><ArticleId IdType="pubmed">22735487</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu I.M., Morimoto E.T.A.A., Goodarzi H., Liao J.T., O&#x2019;Keeffe S., Phatnani H.P., Muratet M., Carroll M.C., Levy S., Tavazoie S., et al. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 2013;4:385&#x2013;401. doi: 10.1016/j.celrep.2013.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.018</ArticleId><ArticleId IdType="pmc">PMC4272581</ArticleId><ArticleId IdType="pubmed">23850290</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Beers D.R., Appel S.H. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J. Neuroimmune Pharmacol. Off. J. Soc. NeuroImmune Pharmacol. 2013;8:888&#x2013;899. doi: 10.1007/s11481-013-9489-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-013-9489-x</ArticleId><ArticleId IdType="pmc">PMC4126425</ArticleId><ArticleId IdType="pubmed">23881705</ArticleId></ArticleIdList></Reference><Reference><Citation>Geloso M.C., Corvino V., Marchese E., Serrano A., Michetti F., D&#x2019;Ambrosi N. The dual role of microglia in ALS: Mechanisms and therapeutic approaches. Front. Aging Neurosci. 2017;9:242. doi: 10.3389/fnagi.2017.00242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00242</ArticleId><ArticleId IdType="pmc">PMC5524666</ArticleId><ArticleId IdType="pubmed">28790913</ArticleId></ArticleIdList></Reference><Reference><Citation>Ransohoff R.M. A polarizing question: Do M1 and M2 microglia exist? Nat. Neurosci. 2016;19:987&#x2013;991. doi: 10.1038/nn.4338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4338</ArticleId><ArticleId IdType="pubmed">27459405</ArticleId></ArticleIdList></Reference><Reference><Citation>Gravel M., B&#xe9;land L.-C.C., Ve Soucy G., Abdelhamid E., Rahimian R., Gravel C., Kriz J., Soucy G., Abdelhamid E., Rahimian R., et al. Il-10 controls early microglial phenotypes and disease onset in ALS caused by misfolded superoxide dismutase 1. J. Neurosci. 2016;36:1031&#x2013;1048. doi: 10.1523/JNEUROSCI.0854-15.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0854-15.2016</ArticleId><ArticleId IdType="pmc">PMC6601999</ArticleId><ArticleId IdType="pubmed">26791230</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohgomori T., Yamada J., Takeuchi H., Kadomatsu K., Jinno S. Comparative morphometric analysis of microglia in the spinal cord of SOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 2016;43:1340&#x2013;1351. doi: 10.1111/ejn.13227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.13227</ArticleId><ArticleId IdType="pubmed">26946061</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha C., Santos C., Gomes C., Fernandes A., Correia A.M., Sebasti&#xe3;o A.M., Vaz A.R., Brites D. Downregulated Glia Interplay and Increased miRNA-155 as Promising Markers to Track ALS at an Early Stage. Mol. Neurobiol. 2018;55:4207&#x2013;4224. doi: 10.1007/s12035-017-0631-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0631-2</ArticleId><ArticleId IdType="pubmed">28612258</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ambrosi N., Finocchi P., Apolloni S., Cozzolino M., Ferri A., Padovano V., Pietrini G., Carr&#xec; M.T., Volont&#xe9; C. The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis. J. Immunol. 2009;183:4648&#x2013;4656. doi: 10.4049/jimmunol.0901212.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0901212</ArticleId><ArticleId IdType="pubmed">19734218</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Q., Zhao W., Beers D.R., Yen A.A., Xie W., Henkel J.S., Appel S.H. Mutant SOD1(G93A) microglia are more neurotoxic relative to wild-type microglia. J. Neurochem. 2007;102:2008&#x2013;2019. doi: 10.1111/j.1471-4159.2007.04677.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2007.04677.x</ArticleId><ArticleId IdType="pubmed">17555556</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes A.E., Ferraiuolo L., Haidet-Phillips A.M., Schmelzer L., Braun L., Miranda C.J., Ladner K.J., Bevan A.K., Foust K.D., Godbout J.P., et al. Microglia induce motor neuron death via the classical NF-$&#x3ba;$B pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Beers D.R., Bell S., Wang J., Wen S., Baloh R.H., Appel S.H. TDP-43 activates microglia through NF-&#x3ba;B and NLRP3 inflammasome. Exp. Neurol. 2015;273:24&#x2013;35. doi: 10.1016/j.expneurol.2015.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.07.019</ArticleId><ArticleId IdType="pubmed">26222336</ArticleId></ArticleIdList></Reference><Reference><Citation>King A.E., Woodhouse A., Kirkcaldie M.T.K., Vickers J.C. Excitotoxicity in ALS: Overstimulation, or overreaction? Pt 1Exp. Neurol. 2016;275:162&#x2013;171. doi: 10.1016/j.expneurol.2015.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.09.019</ArticleId><ArticleId IdType="pubmed">26584004</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe1;l B., Rose C.R., Wittner L., Vaz S.H., Armada-Moreira A., Gomes J.I., Campos Pina C., Savchak O.K., Gon&#xe7;alves-Ribeiro J., Rei N., et al. Going the Extra (Synaptic) Mile: Excitotoxicity as the Road Toward Neurodegenerative Diseases. Front. Cell. Neurosci. 2020;14:90. doi: 10.3389/fncel.2020.00090.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00090</ArticleId><ArticleId IdType="pmc">PMC7194075</ArticleId><ArticleId IdType="pubmed">32390802</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacino T., Musazzi L., Milanese M., Seguini M., Marte A., Gallia E., Cattaneo L., Onofri F., Popoli M., Bonanno G. Altered mechanisms underlying the abnormal glutamate release in amyotrophic lateral sclerosis at a pre-symptomatic stage of the disease. Neurobiol. Dis. 2016;95:122&#x2013;133. doi: 10.1016/j.nbd.2016.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.07.011</ArticleId><ArticleId IdType="pubmed">27425885</ArticleId></ArticleIdList></Reference><Reference><Citation>Milanese M., Bonifacino T., Fedele E., Rebosio C., Cattaneo L., Benfenati F., Usai C., Bonanno G. Exocytosis regulates trafficking of GABA and glycine heterotransporters in spinal cord glutamatergic synapses: A mechanism for the excessive heterotransporter-induced release of glutamate in experimental amyotrophic lateral sclerosis. Neurobiol. Dis. 2015;74:314&#x2013;324. doi: 10.1016/j.nbd.2014.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.12.004</ArticleId><ArticleId IdType="pubmed">25497732</ArticleId></ArticleIdList></Reference><Reference><Citation>Milanese M., Zappettini S., Onofri F., Musazzi L., Tardito D., Bonifacino T., Messa M., Racagni G., Usai C., Benfenati F., et al. Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis. J. Neurochem. 2011;116:1028&#x2013;1042. doi: 10.1111/j.1471-4159.2010.07155.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.07155.x</ArticleId><ArticleId IdType="pubmed">21175617</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson B., Gendron T.F., Staff N.P. Amyotrophic Lateral Sclerosis: An Update for 2018. Mayo Clin. Proc. 2018;93:1617&#x2013;1628. doi: 10.1016/j.mayocp.2018.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2018.04.007</ArticleId><ArticleId IdType="pubmed">30401437</ArticleId></ArticleIdList></Reference><Reference><Citation>Pehar M., Harlan B.A., Killoy K.M., Vargas M.R. Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis. Curr. Pharm. Des. 2017;23:5010&#x2013;5021. doi: 10.2174/1381612823666170622095802.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612823666170622095802</ArticleId><ArticleId IdType="pmc">PMC5740017</ArticleId><ArticleId IdType="pubmed">28641533</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi H., Jin S., Wang J., Zhang G., Kawanokuchi J., Kuno R., Sonobe Y., Mizuno T., Suzumura A. Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J. Biol. Chem. 2006;281:21362&#x2013;21368. doi: 10.1074/jbc.M600504200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M600504200</ArticleId><ArticleId IdType="pubmed">16720574</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B.-S., Ferreira R., Lively S., Schlichter L.C. Microglial SK3 and SK4 currents and activation state are modulated by the neuroprotective drug, riluzole. J. Neuroimmune Pharmacol. Off. J. Soc. NeuroImmune Pharmacol. 2013;8:227&#x2013;237. doi: 10.1007/s11481-012-9365-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-012-9365-0</ArticleId><ArticleId IdType="pubmed">22527636</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesci P., Za&#xef;di S., Lobsiger C.S., Millecamps S., Escartin C., Seilhean D., Sato H., Mallat M., Boill&#xe9;e S. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice. Brain. 2015;138:53&#x2013;68. doi: 10.1093/brain/awu312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu312</ArticleId><ArticleId IdType="pmc">PMC4441079</ArticleId><ArticleId IdType="pubmed">25384799</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomiyama M., Kimura T., Maeda T., Tanaka H., Furusawa K., Kurahashi K., Matsunaga M. Expression of metabotropic glutamate receptor mRNAs in the human spinal cord: Implications for selective vulnerability of spinal motor neurons in amyotrophic lateral sclerosis. J. Neurol. Sci. 2001;189:65&#x2013;69. doi: 10.1016/S0022-510X(01)00561-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(01)00561-5</ArticleId><ArticleId IdType="pubmed">11535235</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronica E., Catania M.V., Geurts J., Yankaya B., Troost D. Immunohistochemical localization of group I and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: Upregulation in reactive astrocytes. Neuroscience. 2001;105:509&#x2013;520. doi: 10.1016/S0306-4522(01)00181-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0306-4522(01)00181-6</ArticleId><ArticleId IdType="pubmed">11672616</ArticleId></ArticleIdList></Reference><Reference><Citation>Valerio A., Ferrario M., Paterlini M., Liberini P., Moretto G., Cairns N.J., Pizzi M., Spano P.F. Spinal cord mGlu1a receptors: Possible target for amyotrophic lateral sclerosis therapy. Pharmacol. Biochem. Behav. 2002;73:447&#x2013;454. doi: 10.1016/S0091-3057(02)00835-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0091-3057(02)00835-3</ArticleId><ArticleId IdType="pubmed">12117600</ArticleId></ArticleIdList></Reference><Reference><Citation>Anneser J.M.H., Ince P.G., Shaw P.J., Borasio G.D. Differential expression of mGluR5 in human lumbosacral motoneurons. Neuroreport. 2004;15:271&#x2013;273. doi: 10.1097/00001756-200402090-00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-200402090-00012</ArticleId><ArticleId IdType="pubmed">15076751</ArticleId></ArticleIdList></Reference><Reference><Citation>Anneser J.M.H., Chahli C., Borasio G.D. Protective effect of metabotropic glutamate receptor inhibition on amyotrophic lateral sclerosis-cerebrospinal fluid toxicity in vitro. Neuroscience. 2006;141:1879&#x2013;1886. doi: 10.1016/j.neuroscience.2006.05.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2006.05.044</ArticleId><ArticleId IdType="pubmed">16820266</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L., Ostrovsky H., Miles G., Lipski J., Funk G.D., Nicholson L.F.B. Differential expression of group I metabotropic glutamate receptors in human motoneurons at low and high risk of degeneration in amyotrophic lateral sclerosis. Neuroscience. 2006;143:95&#x2013;104. doi: 10.1016/j.neuroscience.2006.07.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2006.07.058</ArticleId><ArticleId IdType="pubmed">16979830</ArticleId></ArticleIdList></Reference><Reference><Citation>Anneser J.M.H., Chahli C., Ince P.G., Borasio G.D., Shaw P.J. Glial proliferation and metabotropic glutamate receptor expression in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2004;63:831&#x2013;840. doi: 10.1093/jnen/63.8.831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/63.8.831</ArticleId><ArticleId IdType="pubmed">15330338</ArticleId></ArticleIdList></Reference><Reference><Citation>Planas-Font&#xe1;nez T.M., Dreyfus C.F., Saitta K.S. Reactive Astrocytes as Therapeutic Targets for Brain Degenerative Diseases: Roles Played by Metabotropic Glutamate Receptors. Neurochem. Res. 2020;45:541&#x2013;550. doi: 10.1007/s11064-020-02968-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-020-02968-6</ArticleId><ArticleId IdType="pmc">PMC7058558</ArticleId><ArticleId IdType="pubmed">31983009</ArticleId></ArticleIdList></Reference><Reference><Citation>Vergouts M., Doyen P.J., Peeters M., Opsomer R., Hermans E. Constitutive downregulation protein kinase C epsilon in hSOD1(G93A) astrocytes influences mGluR5 signaling and the regulation of glutamate uptake. Glia. 2018;66:749&#x2013;761. doi: 10.1002/glia.23279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23279</ArticleId><ArticleId IdType="pubmed">29266405</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi D., Brambilla L., Valori C.F., Roncoroni C., Crugnola A., Yokota T., Bredesen D.E., Volterra A. Focal degeneration of astrocytes in amyotrophic lateral sclerosis. Cell Death Differ. 2008;15:1691&#x2013;1700. doi: 10.1038/cdd.2008.99.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2008.99</ArticleId><ArticleId IdType="pubmed">18617894</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeiren C., De Hemptinne I., Vanhoutte N., Tilleux S., Maloteaux J.-M.M., Hermans E., Hemptinne I., Vanhoutte N., Tilleux S., Maloteaux J.-M.M., et al. Loss of metabotropic glutamate receptor-mediated regulation of glutamate transport in chemically activated astrocytes in a rat model of amyotrophic lateral sclerosis. J. Neurochem. 2006;96:719&#x2013;731. doi: 10.1111/j.1471-4159.2005.03577.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2005.03577.x</ArticleId><ArticleId IdType="pubmed">16371010</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Antoni S., Berretta A., Seminara G., Longone P., Giuffrida-Stella A.M., Battaglia G., Sortino M.A., Nicoletti F., Catania M. V A prolonged pharmacological blockade of type-5 metabotropic glutamate receptors protects cultured spinal cord motor neurons against excitotoxic death. Neurobiol. Dis. 2011;42:252&#x2013;264. doi: 10.1016/j.nbd.2011.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.01.013</ArticleId><ArticleId IdType="pubmed">21232601</ArticleId></ArticleIdList></Reference><Reference><Citation>Martorana F., Brambilla L., Valori C.F., Bergamaschi C., Roncoroni C., Aronica E., Volterra A., Bezzi P., Rossi D. The BH4 domain of Bcl-X(L) rescues astrocyte degeneration in amyotrophic lateral sclerosis by modulating intracellular calcium signals. Hum. Mol. Genet. 2012;21:826&#x2013;840. doi: 10.1093/hmg/ddr513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr513</ArticleId><ArticleId IdType="pubmed">22072391</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.-Q., Tueckmantel W., Zhu A., Pellegrino D., Brownell A.-L. Synthesis and preliminary biological evaluation of 3-[(18)F]fluoro-5-(2-pyridinylethynyl)benzonitrile as a PET radiotracer for imaging metabotropic glutamate receptor subtype 5. Synapse. 2007;61:951&#x2013;961. doi: 10.1002/syn.20445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/syn.20445</ArticleId><ArticleId IdType="pubmed">17787003</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrino D., Cicchetti F., Wang X., Zhu A., Yu M., Saint-Pierre M., Brownell A.-L. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats. J. Nucl. Med. 2007;48:1147&#x2013;1153. doi: 10.2967/jnumed.106.037796.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.106.037796</ArticleId><ArticleId IdType="pubmed">17574972</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Pernaute R., Wang J.-Q., Kuruppu D., Cao L., Tueckmantel W., Kozikowski A., Isacson O., Brownell A.-L. Enhanced binding of metabotropic glutamate receptor type 5 (mGluR5) PET tracers in the brain of parkinsonian primates. Neuroimage. 2008;42:248&#x2013;251. doi: 10.1016/j.neuroimage.2008.04.170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2008.04.170</ArticleId><ArticleId IdType="pmc">PMC2532975</ArticleId><ArticleId IdType="pubmed">18501638</ArticleId></ArticleIdList></Reference><Reference><Citation>Brownell A.L., Kuruppu D., Kil K.E., Jokivarsi K., Poutiainen P., Zhu A., Maxwell M. PET imaging studies show enhanced expression of mGluR5 and inflammatory response during progressive degeneration in ALS mouse model expressing SOD1-G93A gene. J. Neuroinflamm. 2015;12:217. doi: 10.1186/s12974-015-0439-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-015-0439-9</ArticleId><ArticleId IdType="pmc">PMC4657381</ArticleId><ArticleId IdType="pubmed">26597638</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#xfc;rcher N.R., Loggia M.L., Lawson R., Chonde D.B., Izquierdo-Garcia D., Yasek J.E., Akeju O., Catana C., Rosen B.R., Cudkowicz M.E., et al. Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: Assessed with [(11)C]-PBR28. NeuroImage. Clin. 2015;7:409&#x2013;414. doi: 10.1016/j.nicl.2015.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2015.01.009</ArticleId><ArticleId IdType="pmc">PMC4310932</ArticleId><ArticleId IdType="pubmed">25685708</ArticleId></ArticleIdList></Reference><Reference><Citation>Milanese M., Zappettini S., Jacchetti E., Bonifacino T., Cervetto C., Usai C., Bonanno G. In vitro activation of GAT1 transporters expressed in spinal cord gliosomes stimulates glutamate release that is abnormally elevated in the SOD1/G93A(+) mouse model of amyotrophic lateral sclerosis. J. Neurochem. 2010;113:489&#x2013;501. doi: 10.1111/j.1471-4159.2010.06628.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.06628.x</ArticleId><ArticleId IdType="pubmed">20132478</ArticleId></ArticleIdList></Reference><Reference><Citation>Milanese M., Giribaldi F., Melone M., Bonifacino T., Musante I., Carminati E., Rossi P.I.A., Vergani L., Voci A., Conti F., et al. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2014;64:48&#x2013;59. doi: 10.1016/j.nbd.2013.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.11.006</ArticleId><ArticleId IdType="pubmed">24361555</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacino T., Cattaneo L., Gallia E., Puliti A., Melone M., Provenzano F., Bossi S., Musante I., Usai C., Conti F., et al. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Neuropharmacology. 2017;123:433&#x2013;445. doi: 10.1016/j.neuropharm.2017.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2017.06.020</ArticleId><ArticleId IdType="pubmed">28645622</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacino T., Provenzano F., Gallia E., Ravera S., Torazza C., Bossi S., Ferrando S., Puliti A., Van Den Bosch L., Bonanno G., et al. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2019;129:79&#x2013;92. doi: 10.1016/j.nbd.2019.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.05.007</ArticleId><ArticleId IdType="pubmed">31102766</ArticleId></ArticleIdList></Reference><Reference><Citation>Milanese M., Bonifacino T., Torazza C., Provenzano F., Kumar M., Ravera S., Arianna, Zerbo R., Frumento G., Balbi M., et al. Blocking glutamate mGlu 5 receptors with the negative allosteric modulator CTEP improves disease course in SOD1 G93A mouse model of amyotrophic lateral sclerosis. Br. J. Pharmacol. 2021;178:3747&#x2013;3764. doi: 10.1111/bph.15515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15515</ArticleId><ArticleId IdType="pmc">PMC8457068</ArticleId><ArticleId IdType="pubmed">33931856</ArticleId></ArticleIdList></Reference><Reference><Citation>Kriz J., Nguyen M.D., Julien J.-P. Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2002;10:268&#x2013;278. doi: 10.1006/nbdi.2002.0487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2002.0487</ArticleId><ArticleId IdType="pubmed">12270689</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Bosch L., Tilkin P., Lemmens G., Robberecht W. Minocycline delays disease onset and mortality in a transgenic model of ALS. Neuroreport. 2002;13:1067&#x2013;1070. doi: 10.1097/00001756-200206120-00018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-200206120-00018</ArticleId><ArticleId IdType="pubmed">12060810</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S., Stavrovskaya I.G., Drozda M., Kim B.Y.S., Ona V., Li M., Sarang S., Liu A.S., Hartley D.M., Wu D.C., et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature. 2002;417:74&#x2013;78. doi: 10.1038/417074a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/417074a</ArticleId><ArticleId IdType="pubmed">11986668</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller A.F., Gravel M., Kriz J. Treatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice. Exp. Neurol. 2011;228:69&#x2013;79. doi: 10.1016/j.expneurol.2010.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2010.12.010</ArticleId><ArticleId IdType="pubmed">21168408</ArticleId></ArticleIdList></Reference><Reference><Citation>Song G.J., Suk K. Pharmacological Modulation of Functional Phenotypes of Microglia in Neurodegenerative Diseases. Front. Aging Neurosci. 2017;9:139. doi: 10.3389/fnagi.2017.00139.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00139</ArticleId><ArticleId IdType="pmc">PMC5430023</ArticleId><ArticleId IdType="pubmed">28555105</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z., Liu B., Yang L.-E., Zhang C. Platycodigenin as Potential Drug Candidate for Alzheimer&#x2019;s Disease via Modulating Microglial Polarization and Neurite Regeneration. Molecules. 2019;24:3207. doi: 10.3390/molecules24183207.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24183207</ArticleId><ArticleId IdType="pmc">PMC6767002</ArticleId><ArticleId IdType="pubmed">31487775</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B., Wei Y.-Z., Wang G.-Q., Li D.-D., Shi J.-S., Zhang F. Targeting MAPK Pathways by Naringenin Modulates Microglia M1/M2 Polarization in Lipopolysaccharide-Stimulated Cultures. Front. Cell. Neurosci. 2018;12:531. doi: 10.3389/fncel.2018.00531.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00531</ArticleId><ArticleId IdType="pmc">PMC6336899</ArticleId><ArticleId IdType="pubmed">30687017</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X., Xiao L., Zhong Z., Wang L., Li Z., Pan X., Liu Z. Astaxanthin acts via LRP-1 to inhibit inflammation and reverse lipopolysaccharide-induced M1/M2 polarization of microglial cells. Oncotarget. 2017;8:69370&#x2013;69385. doi: 10.18632/oncotarget.20628.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.20628</ArticleId><ArticleId IdType="pmc">PMC5642485</ArticleId><ArticleId IdType="pubmed">29050210</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelosa P., Bonfanti E., Castiglioni L., Delgado-Garcia J.M., Gruart A., Fontana L., Gotti M., Tremoli E., Lecca D., Fumagalli M., et al. Improvement of fiber connectivity and functional recovery after stroke by montelukast, an available and safe anti-asthmatic drug. Pharmacol. Res. 2019;142:223&#x2013;236. doi: 10.1016/j.phrs.2019.02.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2019.02.025</ArticleId><ArticleId IdType="pubmed">30818044</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>